deferoxamine has been researched along with aluminum in 361 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 177 (49.03) | 18.7374 |
| 1990's | 143 (39.61) | 18.2507 |
| 2000's | 21 (5.82) | 29.6817 |
| 2010's | 18 (4.99) | 24.3611 |
| 2020's | 2 (0.55) | 2.80 |
| Authors | Studies |
|---|---|
| Luckey, M; Neilands, JB; Wayne, R | 1 |
| Abdel-Latif, AA; Akhtar, RA; Tachado, SD; Zhou, CJ | 1 |
| Becaus, I; Boelaert, JR; D'Haese, PC; De Broe, ME; Lamberts, LV; Verpooten, GA | 1 |
| Brown, MA; Corrigan, AB; Dunstan, CR; George, CR; Kalowski, S | 1 |
| Allinne, E; Bardin, T; Drüeke, TB; Geffriaud, C; Jucquel, JP; Page, B; Zingraff, J | 1 |
| Achard, JM; Ben Hamida, F; Bouzernidj, M; el Esjer, N; Fournier, A; Ghazali, A; Morinière, P; Shenovda, M; Westeel, PF | 1 |
| Greger, JL; Powers, CF | 1 |
| Bansal, M; DeVita, MV; Gardenswartz, MH; Gleim, GW; Michelis, MF; Rasenas, LL; Zabetakis, PM | 1 |
| Nakazawa, R | 2 |
| Kurihara, S; Marumo, F | 1 |
| Arnaud, A; Bongiorno, P; Caligaris, F; Canavese, C; Cardelli, R; D'Amicone, M; Gurioli, L; Marchiori, M; Mattiello, G | 1 |
| Favarato, M; Krishnan, B; Kruck, TP; McLachlan, DR; Mizzen, CA; Sutherland, MK | 1 |
| Fenton, S; Greenwood, C; Hercz, G; Manuel, A; Pei, Y; Saiphoo, C; Segre, G; Sherrard, D | 1 |
| D'Haese, PC; De Broe, ME; Digenis, PN; Lamberts, LV; Lemoniatou, E; Vasilakakis, DM | 1 |
| D'Elia, JA; Min, DI | 1 |
| Ballanti, P; Bondatti, F; Coen, G; Costantini, S; Giordano, R; Manni, M; Mazzaferro, S; Pasquali, M; Perruzza, I; Sardella, D | 1 |
| Huang, CC; Huang, JY; Leu, ML; Lim, PS; Wu, MS | 1 |
| Verbeelen, D | 1 |
| Mactier, RA | 1 |
| Cannata, JB; Diaz López, JB | 1 |
| Botsch, G; Felgenhauer, K; Haug, BA | 1 |
| Abe, F; Hotchi, M; Ito, M; Kaneko, T; Okada, Y; Yamada, K | 1 |
| Fujimoto, Y; Fujita, T; Kondo, Y; Nakajima, M; Sakuma, S; Takai, S | 1 |
| Laurincova, Z; Sulkova, S; Válek, A | 1 |
| García, R; Granadillo, VA; Navarro, JA; Rodríguez-Iturbe, B; Romero, RA; Salgado, O | 1 |
| Harris, DC; Roger, SD; Stewart, JH | 1 |
| Allain, P; Balit, G; Krari, N; Mauras, Y; Subra, JF; Tirot, P; Van-Weydevelt, FC | 1 |
| Amagai, H; Kobayashi, M; Koyama, A; Narita, M; Ohno, A; Yamagata, K; Yoshikawa, S | 1 |
| Anelli, A; Avanzini, G; Brancaccio, D; Bugiani, O; Colantonio, G; Franceschetti, S; Gallieni, M; Martinelli, D; Padovese, P; Panzica, F | 1 |
| Mitrovic, DR; Stankovic, A | 1 |
| Ahmad, R; Helliwell, T; Roberts, N; Yaqoob, M | 1 |
| Ahmad, R; Prabhu, P; Yaqoob, M | 1 |
| Laurinová, Z; Sulková, S; Válek, A | 1 |
| Fyhrquist, F; Rosenlöf, K; Tenhunen, R | 1 |
| Brancaccio, D; Gallieni, M; Galmozzi, C; Padovese, P | 1 |
| Canavese, C; Dogliani, M; Mangiarotti, G; Pacitti, A; Salomone, M; Serra, A; Thea, A | 1 |
| Lowrey, S | 1 |
| Lidums, V; Ungerstedt, U; Yokel, RA | 1 |
| Crocker, JF; Dorcas, VC; Ogborn, MR | 1 |
| van Asbeck, BS; Vlasveld, LT | 1 |
| Izumi, N; Kamikawa, S; Kishimoto, T; Maekawa, M; Tsurusaki, K; Umeda, M; Yasumoto, R | 1 |
| Campise, M; Casati, S; Ponticelli, C | 1 |
| Johnson, WJ; McCarthy, JT; Milliner, DS | 1 |
| Campise, M; Casati, S; Castelnovo, C; Ponticelli, C | 1 |
| Bittar, EE; Huang, YP | 1 |
| Aarseth, HP; Ganss, R | 1 |
| Apostoli, P; De Maria, G; Feller, P; Maiorca, R; Mombelloni, S; Movilli, E; Ravelli, M; Scaroni, P; Sciuto, G; Valotti, C | 1 |
| Fishman, PH; Inoue, Y; Rebois, RV | 1 |
| Chan, MK; Li, CS; Li, MK; Varghese, Z; Wong, WS | 1 |
| Tzamaloukas, AH | 1 |
| Andreoli, SP; Chesney, RW; Salusky, IB; Sedman, AB | 1 |
| Komonová, D; Laurincová, Z; Pancírová, J; Sulková, S; Válek, A | 1 |
| Hashimoto, M; Joko, M; Kaneko, Y; Maruyama, Y; Moriya, A; Motomiya, Y; Okada, H; Ozono, S; Saka, M; Yoshida, K | 1 |
| Chimata, M; Ideura, T; Iwasaki, S; Kawamura, M; Koshikawa, S; Sudo, M; Yoshimura, A | 1 |
| Fisher, EA; Kruck, TP; McLachlan, DR | 1 |
| Cases, A; Griño, MC; Kelly, J; Lopez-Pedret, J; Revert, L; Sabater, F; Torras, A | 1 |
| Donnelly, SM; Smith, EK | 1 |
| Brown, SJ; Dadparvar, S; Slizofski, WJ | 1 |
| Bertram, HP; Winterberg, B | 1 |
| Coburn, JW; Goodman, WG; Nelson, P; Salusky, IB | 1 |
| Almirall, J; Campistol, JM; Revert, L; Torras, A | 1 |
| Hernandez, P; Johnson, CA | 1 |
| Ellenberg, R; King, AL; Posner, M; Savory, J; Sica, DA | 1 |
| Blanco González, E; Cannata, JB; García Alonso, JI; López García, A; Pérez Parajón, J; Sanz Medel, A | 1 |
| Roberts, NB; Williams, P | 1 |
| Hosokawa, S; Oyamaguchi, A; Yoshida, O | 1 |
| Alfrey, AC; Andress, DL; Coburn, JW; Endres, DB; Nebeker, HG; Ott, SM; Sherrard, DJ; Slatopolsky, EA | 1 |
| Lillevang, ST; Pedersen, FB | 1 |
| Alfrey, AC; Griffin, MP; Klein, GL; Miller, NL; Snodgrass, WR | 1 |
| Collart, FE; Dratwa, M; Lenclud, CM; Tielemans, CL; Wens, R | 1 |
| Canavese, C; Constantini, S; D'Amicone, M; Pacitti, A; Pietra, R; Rossi, P; Sabbioni, E; Segoloni, G; Stratta, P; Thea, A | 1 |
| Botta, L; Pavel, J; Schindlery, C; Schmid, K | 1 |
| Altmann, P; Blair, J; Cunningham, J; Dhanesha, U; Hamon, C; Marsh, F | 1 |
| Basile, C; Bourdeau, A; Bourdon, R; Drüeke, T; Dubost, C; Grateau, G; Lacour, B; Ureña, P; Vassault, A; Zingraff, J | 1 |
| Bia, MJ; Cooper, K; Duffy, T; Hendler, E; Malluche, H; Schnall, S; Solomon, L | 1 |
| Alfrey, AC; Contiguglia, RS; Klein, MH; Miller, NL; Mishell, JL; Molitoris, BA; Seligman, PA; Shapiro, JI; Yuan, B | 1 |
| Balabán, D; Kubátko, J; Simícková, J; Syrovátka, P | 1 |
| Kruck, TP; McLachlan, DR | 1 |
| Domingo, JL | 2 |
| Ackrill, P; Day, JP; Hewitt, CD; Hill, K | 1 |
| Abuelo, JG; Blonsky, SL; Chazan, JA | 1 |
| Delmez, J; Lewis-Finch, J; Slatopolsky, E; Weerts, C; Windus, D | 1 |
| Canavese, C; Constantini, S; Giordini, R; Gurioli, L; Mangiarotti, G; Pacitti, A; Salomone, M; Segoloni, G; Stratta, P; Thea, A | 1 |
| Kuramochi, G | 1 |
| Bielakoff, J; Chappuis, P; de Vernejoul, MC; Llach, F; London, G; Marchais, S; Morieux, C | 1 |
| Connor, DJ; Harrell, LE; Jope, RS | 1 |
| Coleman, M; Felsenfeld, AJ; Llach, F; Rodriguez, M; Ross, D | 1 |
| Agness, C; Gonick, HC; Khalil-Manesh, F | 1 |
| de Roy, G; Smeyers-Verbeke, J; van Hooff, I; Verbeelen, D | 2 |
| Bene, C; Bene, D; Kranias, G; Manzler, A | 1 |
| Weiss, LG | 1 |
| Accominotti, M; Ammar, M; Charhon, SA; Mousson, C; Rifle, G | 1 |
| Casteels, R; De Smedt, H; Missiaen, L; Vrolix, M; Wuytack, F | 1 |
| Clark, I; Gutteridge, JM; Halliwell, B; Quinlan, GJ | 1 |
| Kruck, TP; McLachlan, DR; VanBerkum, MF | 1 |
| Albert, FW; Didion, K; Seyfert, UT | 1 |
| Altmann, P; Cunningham, J; Marsh, F; Plowman, D | 1 |
| Collart, F; Dratwa, M; Smeyers-Verbeeke, J; Tielemans, C; Van Hooff, I; Verbeelen, D; Wens, R | 2 |
| Abreo, K; Brown, ST; Sella, M; Trapp, G | 1 |
| Ciaralli, L; Costantini, S; Giordano, R; Ioppolo, A; Rubbiani, M; Vernillo, I | 1 |
| Busch, T; Grabensee, B; Ohnesorge, FK; Passlick, J; Wilhelm, M | 1 |
| Danielson, BG; Fellström, B; Weiss, LG; Wikström, B | 1 |
| Goodman, WG; Namba, R; Oppenheim, WL; Salusky, IB | 1 |
| Accominotti, M; Chapuy, MC; Charhon, SA; Chavassieux, P; Meunier, PJ; Traeger, J | 1 |
| Christoffersen, J; Christoffersen, MR; Thyregod, HC | 1 |
| Coburn, JW; Nebeker, HG | 1 |
| Andriani, M; Brancaccio, D; Gallieni, M; Gilli, P; Malacarne, F; Nordio, M; Piccoli, A; Storari, A | 1 |
| Coburn, JW; Nebeker, HG; Norris, KC | 1 |
| Keogh, JA; McParland, C; O'Brien, AA | 1 |
| Barritt, GJ; Hughes, BP | 1 |
| Andrés, A; Arnaiz, F; de la Serna, J; Estenoz, J; Millet, VG; Nieto, J; Praga, M; Rodicio, JL; Ruilope, LM | 1 |
| Garcia Aznar, A; Modol Gort, J; Soler Amigo, J | 1 |
| Dandona, P; Hoffbrand, AV; Jeremy, JY; Kontoghiorghes, GJ | 1 |
| Alfrey, AC; Alfrey, PS; Miller, NL; Molitoris, BA | 1 |
| Corwin, HL; Goetz, CG; Green, BJ; Sprague, SM; Tanner, CM; Wilson, RS | 1 |
| Boyce, BF; Byars, J; Junor, BJ; Mocan, MZ | 1 |
| Accominotti, M; Beruard, M; Charhon, S; el Yafi, S; Gaillard, M; Janin, G; Meunier, PJ; Traeger, J | 1 |
| Johnson, WJ; Kurtz, SB; McCarthy, JT; Milliner, DS; Schmidt, DF; Schniepp, BJ | 1 |
| Asano, Y; Furuse, M; Homma, S; Hosoda, S; Suzuki, M; Terao, N | 1 |
| Ackrill, P; Ahmed, R; Day, JP | 1 |
| Coburn, JW; Norris, KC | 1 |
| Coburn, JW; Goodman, WG; Howard, N; Norris, KC; Nugent, ME | 1 |
| Massry, SG | 1 |
| Grossman, SD; Smith, LE | 1 |
| Bradley, C; Henderson, AR; Leung, FY; Niblock, AE | 1 |
| Allain, P; Ang, KS; Cam, G; Chaleil, D; Mauras, Y; Simon, P; Varin, MC | 1 |
| Jenny, HB; Peter, HH | 1 |
| Corbella, J; Domingo, JL; Gómez, M; Llobet, JM | 2 |
| Marumo, F; Sato, N; Umetani, N; Yoshida, A | 1 |
| Albonico, C; Colleoni, N; D'Amico, G; Luciani, L; Pagani, C; Rovelli, E | 1 |
| Boykin, JL; Sherrard, DJ; Walker, JV | 1 |
| Alfrey, AC; Bia, M; Coburn, JW; Llach, F; Norris, KC; Sherrard, DJ; Slatopolsky, E | 1 |
| Allain, P; Leblondel, G; Mauras, Y | 1 |
| Fagioli, F; Gilli, P; Locatelli, C | 1 |
| Bar-Khayim, Y; Popovtzer, MM; Smetana, S | 1 |
| Allain, P; Ang, KS; Beaudeau, G; Cam, G; Chaleil, D; Ciancioni, C; Mauras, Y; Poignet, JL; Simon, P; Varin, MC | 1 |
| Abulfil, A; Bab, I; Chaimovitz, C; Gazit, D; Mostovlavsky, M; Rapoport, J | 1 |
| D'Haese, PC; De Broe, ME; Lamberts, LV; Van de Vyver, FL | 1 |
| Coburn, JW; Hercz, G; Miller, JH; Milliner, DS; Nissenson, AR; Shinaberger, JH | 1 |
| Ackrill, P; Day, JP; Ralston, AJ | 1 |
| Andress, DL; Coburn, JW; Maloney, NA; Milliner, DS; Nebeker, HG; Ott, SM; Sherrard, DJ | 1 |
| Faugere, MC; Friedler, RM; Malluche, HH; Smith, AJ | 1 |
| Becker, GJ; Ihle, BU; Kincaid-Smith, PS | 1 |
| Alfrey, AC; Andress, DL; Coburn, JW; Milliner, DS; Nebeker, HG; Ott, SM; Sherrard, DJ; Slatopolsky, EA | 2 |
| Arnala, IO; Faugere, MC; Malluche, HH; Ritz, E | 1 |
| Chan, JC; Massie, MD; Santos, F | 1 |
| Slatopolsky, E | 1 |
| Delmastro, J; Espinoza, O; Gehrung, E; Katz, E; Pérez, A; Roessler, E | 1 |
| Andress, DL; Coburn, JW; Endres, DB; Maloney, NA; Sherrard, DJ | 1 |
| Alfrey, AC; Alfrey, PS; Hasbargen, JA; Kaehney, WD; Miller, NL; Molitoris, BA; Smith, BJ | 1 |
| Abuelo, JG; Goodill, JJ | 1 |
| Al-Salihi, F; Altmann, P; Blair, J; Butter, K; Cunningham, J; Cutler, P; Leeming, R; Marsh, F | 1 |
| Bournerias, F; Dufier, JL; Monnier, N; Réveillaud, RJ | 1 |
| Kurokawa, K; Marumo, F; Ogura, Y; Ono, T; Suzuki, M | 1 |
| Marumo, F; Sato, N; Takahashi, Y; Umetani, N | 1 |
| Allain, P; Ang, KS; Cam, G; Chaleil, D; Le Mignon, L; Mauras, Y; Simon, M; Simon, P | 1 |
| Lesniak, S; Lewis, M | 1 |
| Boivin, G; Chapuy, MC; Charhon, SA; Chavassieux, P; Meunier, PJ; Parisien, M; Traeger, J | 1 |
| Fenves, AZ; Julian, BA; Stokes, TJ; Windus, DW | 1 |
| D'Haese, PC; de Broe, ME; Roodhooft, AM; van Acker, KJ; van de Vyver, FL; Visser, WJ | 1 |
| Keogh, JA; Moore, DP; O'Brien, AA | 1 |
| Kostenbauder, HB; Yokel, RA | 1 |
| Beck, G; Gmeiner, R; König, P; Lechleitner, P | 1 |
| Channon, SM; Kerr, DN; Rahman, H; Skillen, AW; Ward, MK | 1 |
| Bhattacharya, S; Crawford, AJ; Graham, A; Luther, RW; Palmieri, GM; Peters, TG; Pitcock, JA; Spears, H; Vera, SR; Williams, JW | 1 |
| Cameron, EC; Hagen, LE; Hughes, H; Sutton, RA | 1 |
| Abitbol, C; Faugere, MC; Freundlich, M; Malluche, HH; Strauss, J; Zilleruelo, G | 1 |
| Henderson, AR; Hollomby, DJ; Keown, PA; Leung, FY; Mitton, R; Muirhead, N; Stiller, CR | 1 |
| Barré, PE; Prichard, S | 1 |
| Allain, P; Beaudeau, G; Hingouet, P; Mauras, Y | 1 |
| De Roy, G; Smeyers-Verbeke, J; Van der Straeten, A; Van Hooff, I; Verbeelen, D | 1 |
| Aoki, J; Fukuda, T; Hino, M; Iwamoto, N; Kondo, M; Shigeno, C; Torizuka, K; Yamamoto, I; Yamamoto, N; Yamazaki, S | 1 |
| Ford, DM; Gaston, CE; Huffer, WE; Lum, GM; Sedman, AB; Warady, BA | 1 |
| Corwin, HL; Mayor, GH; Sprague, SM; Tanner, CM; Wilson, RS | 1 |
| Andriani, M; Borsatti, A; Nordio, M; Piccoli, A | 1 |
| Bertholf, RL; Savory, J; Wills, MR | 1 |
| Ackrill, P; Day, JP; Garstang, FM; Hewitt, CD; Metcalfe, PJ; O'Hara, M | 1 |
| Bergfeld, M; Chan, YL; Finch, JL; Martin, KJ; Slatopolsky, E; Teitelbaum, S | 1 |
| Chapuy, MC; Charhon, SA; Chavassieux, PM; Meunier, PJ; Traeger, J | 1 |
| Bellomo, G; Orrenius, S; Thor, H | 1 |
| Andress, DL; Coburn, JW; Kopp, JB; Maloney, NA; Sherrard, DJ | 1 |
| Fünfstück, R; Günther, K; Schröter, H; Sperschneider, H; Stein, G; Winnefeld, K | 1 |
| Kurtz, SB; McCarthy, JT; Mussman, GV | 1 |
| Coburn, JW; Fine, RN; Hercz, G; Norris, KC; Salusky, IB | 1 |
| Simon, P | 2 |
| Burnatowska-Hledin, M; Dombrouski, J; Mayor, G; Swartz, R | 1 |
| Ciancioni, C; Delons, S; Man, NK; Mikol, F; Monge, MF; Naret, C; Poignet, JL | 1 |
| Ackrill, P; Day, JP | 4 |
| Swartz, RD | 1 |
| Allain, P; Ang, KS; Cam, G; Mauras, Y; Simon, P | 1 |
| Andreoli, SP; Bergstein, JM; DeMyer, W; Dunn, D; Sherrard, DJ | 1 |
| Fukuda, T; Hino, M; Hiratake, Y; Iwamoto, N; Kondo, M; Kubo, Y; Masugi, Y; Ono, T; Yamamoto, N; Yamazaki, S | 1 |
| Henderson, AR; Hodsman, AB; Leung, FY; Muirhead, N | 1 |
| Kurtz, SB; McCall, JT; McCarthy, JT | 1 |
| Andrew, L; Bachs, M; Bergadä, E; Bonal, J; Löpez Pedret, J; Montoliu, J; Revert, L | 1 |
| Debroe, M; Demontis, R; Fohrer, P; Fournier, A; Lambrey, G; Leflon, P; Moriniere, P; Sebert, JL; Tolani, M; Van Devyver, F | 1 |
| Baldamus, CA; Kaltwasser, JP; Scheuermann, EH; Schmidt, H; Schoeppe, W; Werner, E | 1 |
| Binswanger, U; Gautschi, K; Hess, T; Jungbluth, H | 1 |
| Botella, J; de Miguel, A; Enriques, R; Fernandez-Fernandez, J; Franco, P; Gallego, JL; Ramos, J; Sanz-Guajardo, D; Sanz-Moreno, C | 1 |
| Allain, P; Ciancioni, C; Delons, S; Man, NK; Mauras, Y; Naret, C; Poignet, JL | 1 |
| Kalow, W; Kruck, TP; McLachlan, DR | 1 |
| Berland, Y; Charhon, SA; Meunier, PJ; Olmer, M | 1 |
| Glatzel, E; Köhler, M; Weiland, P | 1 |
| Eisinger, RP; Sherman, RA; Walker, JA | 1 |
| Brown, P; Cordy, PE; Hodsman, AB; Hood, SA | 1 |
| Ando, Y; Asano, Y; Hosoda, S; Kato, K; Sizuki, M; Suka, T; Terao, N | 1 |
| Ackrill, P; Day, JP; Hodge, KC; Ralston, AJ | 1 |
| Adhemar, JP; Galli, A; Jaudon, MC; Kleinknecht, D; Laederich, J; Masselot, JP | 1 |
| Arze, RS; Britton, P; Cartlidge, NE; Parkinson, IS; Ward, MK | 1 |
| Holzer, W; Petek, W; Pogglitsch, H; Wawschinek, O | 1 |
| Brown, DJ; Dawborn, JK; Ham, KN; Xipell, JM | 1 |
| Bell, PD; Meyers, AM; Milne, FJ; Sharf, B | 1 |
| Barre, P; Chang, TM | 1 |
| Fell, GS; Junor, BJ; Payton, CD | 1 |
| Acchiardo, SR; Massie, JD; Palmieri, GM; Pinstein, ML; Scott, RL; Sebes, JI; Williams, JW | 1 |
| Becker, GJ; Buchanan, MR; Ihle, BU; Kincaid-Smith, P; Stevens, B | 1 |
| Shore, D; Wyatt, RJ | 1 |
| Abreo, K; Faugere, MC; Malluche, HH; Smith, AJ | 1 |
| Myli, MP; Pierides, AM | 1 |
| Melograna, JM; Yokel, RA | 2 |
| Casson, IF; Harvey, JN; Lee, MR | 1 |
| Anderson, C; Bolton, CF; Clark, WF; Cordy, PE; Hodsman, AB; Hood, SA; Leung, F | 1 |
| Canavese, C; Luda, E; Rocca, G | 1 |
| Allain, P; Ciancioni, C; Delons, S; Man, NK; Mauras, Y; Panthier, G; Poignet, JL | 1 |
| Canavese, G; D'Amicone, M; Lamon, S; Luda, E; Rubino, GF; Scansetti, G; Segoloni, G; Talarico, S; Vercellone, A | 1 |
| Bell, P; Meyers, AM; Milne, FJ; Sharf, B | 1 |
| Culpepper, CP; Cummings, R; Savory, J; Westervelt, FB; Wills, MR | 1 |
| Baldamus, CA; Bechstein, PB; Fassbinder, W; Hilfenhaus, M; Koch, KM; Schmidt, H | 1 |
| Graf, H; Meisinger, V; Stummvoll, HK | 2 |
| Halstead, BW; Williams, DR | 1 |
| Mason, L; Weinkove, C | 1 |
| Ackrill, P; Ball, J; Benzo, Z; Day, JP; Denton, J; Garstang, FM; Hill, K; Hodge, KC; Metcalfe, PJ; Ralston, AJ | 1 |
| Allain, P; Ang, KS; Mauras, Y; Simon, P; Tanquerel, T | 1 |
| Kontoghiorghes, GJ | 1 |
| Boyd, JC; Herman, MM; Huang, Y; Nicholson, JR; Reyes, MR; Savory, J; Wills, MR | 1 |
| Erasmus, RT; Herman, MM; Kusnir, J; Lobo, P; Savory, J; Stevenson, WC; Wills, MR | 1 |
| Dittert, DD; Warnecke, G; Willert, HG | 1 |
| Komatsu, M; McDermott, AM; Sharp, GW | 1 |
| Akaishi, Y; Hattori, Y; Imamura, M; Kanno, M | 1 |
| Acuña Aguerre, G; Cannata Andía, JB; Douthat, WG; Fernández Martín, JL; Mouzo, R | 1 |
| Ionova, D; Kambova, L; Kirijakov, Z | 1 |
| Cannata-Andía, JB; Canteros, MA; Díaz-López, JB; Fernández-Martín, JL; Menéndez-Fraga, P | 1 |
| Farber, JL; Savory, J; Serroni, A; Snyder, JW | 1 |
| Corbella, J; del Castillo, D; Domingo, JL; Gómez, M; Llobet, JM | 1 |
| Borelli, A; Coutris, G; Crivellari, ME; Jorgetti, V; Leite, MO; Marcondes, M; Mendes, V; Nussenzweig, I; Pereira, RC; Soeiro, NM | 1 |
| Vogelsang, U | 1 |
| Ecelbarger, CA; Greger, JL; MacNeil, GG | 1 |
| Romero, RA | 1 |
| Kruck, TP; McLachlan, DR; Smith, WL | 1 |
| Arakelian, S; Babloyan, A; D'Haese, PC; De Broe, ME; Digenis, P; Jurgens, A; Lamberts, LV; Tjalma, W; Vaneerdeweg, W; Verpooten, GA | 1 |
| Alonso, R; Arcocha, V; Correa, B; Lens, XM; Martín, C; Prieto, A; Soto, A | 1 |
| Adamczak, H; Głuszek, J | 1 |
| Aquino, A; Capobianco, A; Lauriello, F; Pacia, S; Panico, F; Salvati, A; Scoppa, F; Taccone, W; Tedesco, V; Testa, GF | 1 |
| Davie, MW; Day, JP; Perks, J; Sharp, CA; Worsfold, M | 1 |
| Yokel, RA | 1 |
| Marx, JJ; Voest, EE; Vreugdenhil, G | 1 |
| Caputo, CB; Fieles, A; Scott, CW; Sygowski, LA | 1 |
| Emans, J; Goodman, W; Harman, W; Mathias, R; Paredes, A; Salusky, I; Segre, G | 1 |
| Sulková, S | 1 |
| Kontoghiorghes, GJ; Sheppard, LN | 1 |
| Bell, JD; Kubal, G; Radulovic, S; Sadler, PJ; Tucker, A | 1 |
| Yawalkar, SJ | 1 |
| Couttenye, MM; D'Haese, PC; De Broe, ME; Lamberts, LV; Van Landeghem, GF | 1 |
| Hummel, S; Hümpfner, A; Schulz, W | 1 |
| Olivero, JJ | 1 |
| Alonso, MC; Alonso, R; Arcocha, V; Arza, D; Lens, XM; Novoa, D; Otero, S; Romero, R; Sanchez-Guisande, D | 1 |
| Ahmad, R; Fahal, IH; Helliwell, T; McClelland, P; Roberts, NB; Sallomi, DF; Shivakumar, KA; Yaqoob, M | 1 |
| Ritz, E | 1 |
| Ambrus, CM; Anthone, R; Anthone, S; Kohli, R; Min, I; Stadler, A; Stadler, I; Vladutiu, A | 1 |
| Barsoum, RS; Couttenye, MM; D'Haese, PC; De Broe, ME; Digenis, P; Fagalde, A; Goodman, WG; Lamberts, LV; Lemoniatou, E; Sotornik, I | 1 |
| Gill, KD; Julka, D | 3 |
| Furman, WL; Jenkins, JJ; Kanwar, VS; Mandrell, BN | 1 |
| Boelaert, JR; De Brauwer, E; Gordts, B; Lin, SH; Lin, YF; Shieh, SD; Van Landuyt, HW | 1 |
| Barata, JD; D'Haese, PC; De Broe, ME; Lamberts, LV; Pires, C; Simões, J | 1 |
| Di Iorio, B; Terracciano, V | 1 |
| Andriani, M; Nordio, M; Saporiti, E | 1 |
| Exley, C; Forbes, WF; Huang, Y; Joshi, JG; Kruck, T; McLachlan, DR; Savory, J; Wakayama, I | 1 |
| Ackrill, P; Burgess, E; Day, JP; Domingo, JL; Flaten, TP; Savory, J; Yokel, RA | 1 |
| Acuña, G; Alonso, M; Alvarez-Grande, J; Cannata, JB; Caramelo, C; Díaz-López, B; Fernández-Martín, JL; Olaizola, I | 1 |
| Fredenburg, AM; Meurer, KA; Skinner, TL; Yokel, RA | 1 |
| Couttenye, MM; D'Haese, PC; De Broe, ME | 1 |
| Cannata Andía, JB | 1 |
| Crichton, RR; Florence, AL; Gauthier, A; Ward, RJ | 1 |
| Danielsen, CC; Gordeladze, JO; Jablonski, G; Klem, KH; Mosekilde, L | 1 |
| Janssen, MJ; van Boven, WP | 1 |
| Elejalde, LE; Rodríguez-Iturbe, B; Romero, RA; Salgado, O; Tahán, JE | 1 |
| Günther, K; Klemm, A; Sperschneider, H; Stein, G; Winnefeld, K | 1 |
| Juzwiuk, J; Kalinowski, M; Kaliszewski, Z; Popławski, A | 1 |
| Barata, JD; D'Haese, PC; De Broe, ME; Lamberts, LV; Van Landeghem, GF | 1 |
| Wang, G; Wang, S; Zhu, P | 1 |
| Ballanti, P; Bonucci, E; Ciaralli, L; Cinotti, GA; Coen, G; Costantini, S; Giordano, R; Mazzaferro, S; Onorato, L; Pasquali, M; Perruzza, I; Sardella, D | 1 |
| Huang, TP; Tarng, DC | 1 |
| Porter, DJ | 1 |
| Herman, MM; Huang, Y; Savory, J; Wills, MR | 1 |
| Blanco-González, E; Cannata-Andía, JB; Fernández-Martín, JL; Menéndez-Fraga, P | 1 |
| Cannata, J; Canteros, A; Díaz-Corte, C; Fernández-Martín, JL; Fernández-Merayo, C; Gago, E | 1 |
| Nasu, T; Suzuki, N | 1 |
| Domingo, JL; Esparza, JL; Gómez, M; Jones, MM; Singh, PK | 2 |
| Berthon, G; Biron, F; Desroches, S | 1 |
| Higuchi, J; Kitamoto, T; Muramoto, T; Murayama, H; Shibuya, S; Shin, RW | 1 |
| Andrade, R; Catarino, MC; Cruz, A; Ferreira, A; Gil, C; Jorge, C; Possante, M; Santos, N; Teixeira, R | 1 |
| Poltera, AA | 1 |
| Blanusa, M; Jones, MM; Kostial, K; Pavlović, D; Prester, L; Singh, PK; Varnai, VM | 1 |
| del Castillo, D; Domingo, JL; Esparza, JL; Gómez, M; Hernández, M | 1 |
| Cannata-Andía, JB; Canteros-Picotto, A; Fernández-Martín, JL | 1 |
| Arsenescu, I; Benamar, L; el Esper, N; Fournier, A; Ghitu, S; Morinière, P; Oprisiu, R; Said, S; Tataru Albu, A | 1 |
| Elmore, D; McNamara, PJ; Rhineheimer, SS; Sharma, P; Yokel, RA | 1 |
| Huang, JY; Wu, CH; Wu, MS | 1 |
| Acuña, G; Cannata-Andía, JB; Fernández-Martín, JL; Fernández-Soto, I | 1 |
| Cervini-Silva, J; Sposito, G | 1 |
| Kitamoto, T; Kruck, TP; Murayama, H; Shin, RW | 1 |
| Cannata Andía, JB; Fernández Martín, JL; González Suárez, I; Naves Díaz, M | 1 |
| Kinugasa, E | 1 |
| Cui, JG; Kruck, TP; Lukiw, WJ; Percy, ME | 1 |
| de Vernejoul, MC; Guerin, AP; London, GM; Marchais, SJ; Marty, C; Metivier, F | 1 |
| Fukui, T; Kinugasa, E; Yamamoto, M | 1 |
| Kashiwagi, T; Kurihara, S | 1 |
| Drago, D; Filippi, B; Ricchelli, F; Tognon, G; Zatta, P | 1 |
| Holmes, DT; Sreenivasan, GM; Yong, RL | 1 |
| Friesen, MS; Gair, RD; Purssell, RA | 1 |
| Diskin, CJ; Thomas, CE | 1 |
| Ishii, K; Ogasawara, Y; Saito, H; Sakamoto, T; Takahashi, H; Tanabe, S | 1 |
| Chien, CC; Hwang, JC; Kan, WC; Su, SB; Wang, HY; Wu, CC | 1 |
| Domingo, JL; Esparza, JL; Garcia, T; Giralt, M; Gómez, M; Nogués, MR | 1 |
| Boehm, ME; Haaf, E; Lehmann, WD; Schlosser, A; Seidler, J; Winter, D; Zinn, N | 1 |
| Drever, BD; Nday, CM; Platt, B; Salifoglou, T | 1 |
| Campbell, N; Fan, SL; Pepper, R; Roberts, NB; Yaqoob, MM | 1 |
| Kruck, TP; Lukiw, WJ; Percy, ME; Pogue, AI | 1 |
| Raja, B; Sivakumar, S; Sivasubramanian, J | 1 |
| Arteta-Jiménez, M; Hernández-Sánchez, A; Tejada-González, P | 1 |
| Khatiwada, CP; Manivannan, J; Raja, B; Sivakumar, S; Sivasubramanian, J | 1 |
| Khatiwada, CP; Raja, B; Sivakumar, S; Sivasubramanian, J | 2 |
| Di Lorenzo, B; Di Lorenzo, F | 1 |
| Khatiwada, CP; Sivakumar, S; Sivasubramanian, J | 2 |
| Campos, OS; Espósito, BP; Huayhuaz, JAA; Kaneko, TM; Serrano, SHP; Vitorino, HA | 1 |
| Chung, WY; Fiordalisi, C; Kowdley, KV; Messner, DJ; Surrago, C | 1 |
| Canaud, B; Dard, S; Drueke, T; Dupuis, E; Massy, ZA; Seidowsky, A | 1 |
| Dellith, J; Hübner, U; Mayerhöfer, T; Pahlow, S; Popp, J; van der Loh, M; Weber, K | 1 |
| Bahl, A; Bai, J; Campen, MJ; Chai, H; Chen, C; Chen, J; Chen, X; Cheng, L; Cheng, W; Dong, Q; Easton, J; Engberg, E; Fadladdin, YAJ; Franco, PM; Gao, J; Giri, AR; Goodarzi, Z; Graves, SA; Guo, Y; Holroyd-Leduc, J; Hu, Z; Huang, IC; Hudson, MM; Ji, X; Jiang, J; Johnson, S; Kaur, N; Koivusalo, SB; Kulmala, J; Lan, Q; Leng, S; Li, Q; Li, Y; Li, Z; Liang, R; Liu, F; Liu, Y; Lowman, PE; Ma, X; Menda, Y; Mielke, N; Mulder, H; Neale, G; Ness, KK; Niaz, S; Niu, Q; Pang, H; Park, EA; Plyler, E; Qin, N; Qin, X; Qiu, H; Ren, D; Ren, J; Roach, M; Robison, LL; Roine, RP; Rothman, N; Rottman Pietrzak, KA; Sahrakorpi, N; Sanghavi, DK; Santos, C; Shallom, SJ; Song, N; Spotswood, N; Stach-Lempinen, B; Subota, A; Sun, X; Tammelin, TH; Tang, J; Walker, E; Wang, M; Wang, Z; Xie, J; Xu, J; Xue, J; Xue, M; Yang, S; Yang, Y; Yarrarapu, SNS; Yasui, Y; Yu, H; Yu, W; Zelazny, AM; Zhang, H; Zhang, J; Zhang, X; Zheng, Y; Zhu, D | 1 |
| Chen, CL; Chen, MY; Chen, NC; Ou, SH; Yin, CH | 1 |
44 review(s) available for deferoxamine and aluminum
| Article | Year |
|---|---|
Use of alkaline calcium salts as phosphate binder in uremic patients.
Topics: Aluminum; Calcinosis; Calcitriol; Calcium; Deferoxamine; Humans; Hyperparathyroidism, Secondary; Phosphates; Renal Dialysis; Uremia | 1992 |
Insights into the complex aluminium and iron relationship.
Topics: Aluminum; Animals; Biological Transport, Active; Deferoxamine; Erythropoietin; Humans; Iron; Renal Dialysis | 1991 |
Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine.
Topics: Aluminum; Deferoxamine; Female; Humans; Intestinal Diseases; Middle Aged; Mucormycosis; Renal Dialysis; Risk Factors | 1991 |
Diagnosis and management of bone disorders in chronic renal failure and dialyzed patients.
Topics: Aluminum; Biopsy; Bone and Bones; Bone Diseases; Calcitriol; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Humans; Kidney Failure, Chronic; Parathyroid Glands; Radiography; Renal Dialysis | 1990 |
Aluminum as a pathogenic factor in senile dementia of the Alzheimer type: ion specific chelation.
Topics: Aluminum; Alzheimer Disease; Animals; Brain; Chelating Agents; Deferoxamine; Environmental Exposure; Rabbits | 1989 |
The use of chelating agents in the treatment of aluminum overload.
Topics: Aluminum; Chelating Agents; Deferoxamine; Humans | 1989 |
Aluminum and neurodegenerative disease: therapeutic implications.
Topics: Aluminum; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Calcium; Deferoxamine; Dementia; Down Syndrome; Guam; Humans; Nervous System Diseases; Neurofibrils; Neurons; Neurotransmitter Agents; Parkinson Disease, Secondary | 1985 |
Aluminum and renal osteodystrophy.
Topics: 24,25-Dihydroxyvitamin D 3; Aluminum; Animals; Bone and Bones; Calcitriol; Caseins; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Diet; Dihydroxycholecalciferols; Dogs; Drug Therapy, Combination; Humans; Osteomalacia; Parathyroid Hormone; Parenteral Nutrition, Total; Protein Hydrolysates; Rats; Renal Dialysis; Syndrome; Water Supply | 1986 |
Osteomalacia and bone disease arising from aluminum.
Topics: Aluminum; Animals; Bone and Bones; Bone Diseases; Deferoxamine; Humans; Kidney Failure, Chronic; Osteomalacia; Parathyroid Hormone; Parenteral Nutrition, Total; Renal Dialysis | 1986 |
Aluminum and iron overload in chronic dialysis.
Topics: Aluminum; Bone Diseases; Deferoxamine; Humans; Iron; Renal Dialysis; Uremia | 1988 |
Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine.
Topics: Aluminum; Bone Diseases; Deferoxamine; Hematologic Diseases; Humans; Muscular Diseases; Pain; Risk | 1986 |
Iliac crest bone biopsy for diagnosis of aluminum toxicity and a guide to the use of deferoxamine.
Topics: Aluminum; Biopsy; Bone Diseases; Deferoxamine; Humans; Needles | 1986 |
Prevention and treatment of the abnormalities in divalent ion metabolism in renal failure.
Topics: Aluminum; Calcium Metabolism Disorders; Deferoxamine; Humans; Kidney Failure, Chronic; Parathyroid Glands; Phosphates; Renal Dialysis; Vitamin D | 1986 |
Risk factors in aluminum toxicity in children with chronic renal failure.
Topics: Acidosis; Adolescent; Adult; Aluminum; Aluminum Hydroxide; Bone and Bones; Child; Citrates; Citric Acid; Deferoxamine; Humans; Hydrogen-Ion Concentration; Infant; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Risk; Water | 1986 |
Deferoxamine and aluminum removal.
Topics: Aluminum; Bone and Bones; Chelating Agents; Deferoxamine; Dementia; Humans; Iron; Osteomalacia; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1985 |
Detoxification in hemosiderosis.
Topics: Administration, Oral; Adult; Aluminum; Deferoxamine; Hemosiderosis; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Renal Dialysis; Transfusion Reaction | 1985 |
Prevention and treatment of aluminum intoxication in chronic renal failure.
Topics: Aged; Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Kinetics; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Phosphates; Renal Dialysis | 1985 |
Deferoxamine therapy of bone aluminum accumulation in renal dialysis patients.
Topics: Adolescent; Adult; Aluminum; Bone and Bones; Bone Diseases, Metabolic; Chelating Agents; Child; Child, Preschool; Deferoxamine; Humans; Middle Aged; Parenteral Nutrition, Total; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1985 |
Aluminum and Alzheimer's disease.
Topics: Aluminum; Alzheimer Disease; Animals; Brain Chemistry; Cell Nucleus; Cooking and Eating Utensils; Deferoxamine; Dementia; Diet; Female; Fluorides; Hair; Humans; Male; Mice; Middle Aged; Neurofibrils | 1983 |
Chelating agents in medicine.
Topics: Aluminum; Cadmium; Chelating Agents; Chromium; Copper; Deferoxamine; Dimercaprol; Edetic Acid; Environmental Pollutants; Humans; Iron; Mercury; Metals; Molybdenum; Penicillamine; Plutonium; Unithiol | 1982 |
Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs.
Topics: Administration, Oral; Aluminum; Animals; Chelating Agents; Clinical Protocols; Deferiprone; Deferoxamine; Humans; Iron; Iron Chelating Agents; Pyridones | 1995 |
[Aluminum poisoning in dialysis patients--diagnosis and therapy].
Topics: Adult; Aged; Aluminum; Deferoxamine; Female; Hemofiltration; Hemoperfusion; Humans; Male; Middle Aged; Poisoning; Renal Dialysis | 1994 |
Aluminum, vanadium, and lead intoxication of uremic patients undergoing hemodialysis in Venezuela.
Topics: Aluminum; Deferoxamine; Humans; Lead Poisoning; Renal Dialysis; Uremia; Vanadium; Venezuela; Water Pollutants, Chemical | 1994 |
The chemistry of desferrioxamine chelation for aluminum overload in renal dialysis patients.
Topics: Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Renal Dialysis | 1993 |
[Aluminum in chronic renal failure].
Topics: Aluminum; Bone and Bones; Deferoxamine; Humans; Kidney Failure, Chronic; Renal Dialysis; Skin | 1993 |
Aluminum chelation: chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine.
Topics: Adult; Aluminum; Animals; Carboxylic Acids; Chelating Agents; Chelation Therapy; Child; Deferoxamine; Fluorides; Humans; Kidney Failure, Chronic; Nervous System Diseases; Rabbits; Rats; Renal Replacement Therapy | 1994 |
Iron-chelating agents in non-iron overload conditions.
Topics: Aluminum; Animals; Chelating Agents; Deferoxamine; Humans; Iron | 1994 |
Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
Topics: Aluminum; Deferoxamine; Dialysis Solutions; Humans; Kidney Failure, Chronic; Renal Dialysis | 1993 |
Diagnosis and treatment of aluminium overload in end-stage renal failure patients. Consensus conference. Paris, France, 27 June 1992.
Topics: Aluminum; Deferoxamine; Dialysis Solutions; Humans; Kidney Failure, Chronic; Renal Dialysis | 1993 |
The use of desferrioximine in dialysis-associated aluminium disease.
Topics: Aluminum; Anemia; Bone Diseases; Brain Diseases; Deferoxamine; Humans; Kidney Failure, Chronic; Renal Dialysis | 1993 |
Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?
Topics: Aluminum; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Deferoxamine; Environmental Exposure; Humans; Nerve Degeneration; Neurofibrils; Renal Dialysis; Research Design; Risk Factors | 1996 |
Prevention and treatment of aluminum toxicity including chelation therapy: status and research needs.
Topics: Aluminum; Animals; Antidotes; Chelation Therapy; Deferoxamine; Humans; Poisoning; Research Design | 1996 |
Diagnosis and treatment of aluminium bone disease.
Topics: Aluminum; Bone and Bones; Bone Diseases; Deferoxamine; Humans; Parathyroid Hormone; Renal Dialysis | 1996 |
Aluminium toxicity: its relationship with bone and iron metabolism.
Topics: Aluminum; Bone and Bones; Deferoxamine; Erythropoietin; Humans; Iron; Kidney Failure, Chronic; Parathyroid Hormone | 1996 |
Adverse effects of aluminium-chelating compounds for clinical use.
Topics: Aluminum; Animals; Antidotes; Chelating Agents; Deferiprone; Deferoxamine; Humans; Pyridones | 1996 |
[Renal osteodystrophy (3); its treatment in dialysis patients].
Topics: Aluminum; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Humans; Hyperparathyroidism; Osteomalacia; Parathyroidectomy; Renal Dialysis; Vitamin D | 2000 |
[Uremic encephalopathy, dialysis encephalopathy].
Topics: Aluminum; Brain Diseases, Metabolic; Deferoxamine; Diagnosis, Differential; Hemofiltration; Humans; Iron Chelating Agents; Renal Dialysis; Uremia | 2004 |
[Dialysis encephalopathy].
Topics: Aluminum; Deferoxamine; Dementia; Diagnosis, Differential; Dialysis; Dialysis Solutions; Drug Contamination; Humans; Iron Chelating Agents; Prognosis | 2004 |
[Aluminum and iron deposition in dialysis patients].
Topics: Aluminum; Aluminum Hydroxide; Anemia; Bone Diseases, Metabolic; Contraindications; Deferoxamine; Dementia; Diagnosis, Differential; Dialysis; Humans; Iron; Osteomalacia | 2004 |
[The K/DOQI guidelines on diagnosis and treatment of aluminum bone disease in hemodialysis patients].
Topics: Aluminum; Biomarkers; Bone Diseases, Metabolic; Deferoxamine; Hemodiafiltration; Hemodialysis Solutions; Humans; Membranes, Artificial; Parathyroid Hormone; Practice Guidelines as Topic; Renal Dialysis | 2004 |
Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease.
Topics: Aluminum; Alzheimer Disease; Animals; Clinical Trials, Phase II as Topic; Deferoxamine; Environmental Exposure; Gene Expression Regulation; Humans; Reactive Oxygen Species; Siderophores | 2011 |
Aluminium in parenteral nutrition: a systematic review.
Topics: Aluminum; Alzheimer Disease; Bone Diseases, Metabolic; Deferoxamine; Dyslipidemias; Humans; Iron; Ketoglutaric Acids; Liver Diseases; Neurons; Parenteral Nutrition Solutions; Parenteral Nutrition, Total; Risk Factors; Taurine | 2013 |
[Aluminic intoxication in chronic hemodialysis. A diagnosis rarely evoked nowadays. Clinical case and review of the literature].
Topics: Aluminum; Brain Diseases; Deferoxamine; Electrocardiography; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2018 |
Topics: Adult; Aging; Aluminum; Alzheimer Disease; Animals; Anti-Bacterial Agents; Artemisia annua; Body Mass Index; Brain; Canada; Cancer Survivors; Cardiovascular Diseases; Child; Clarithromycin; Cohort Studies; Cricetinae; Critical Care; Cross-Sectional Studies; Deferoxamine; Dementia; Depression; Diabetes Mellitus, Type 2; Diabetes, Gestational; DNA Methylation; Drug Resistance, Bacterial; Endothelial Cells; Epigenesis, Genetic; Exercise; Female; Ferroptosis; Garlic; Genetic Loci; Genome-Wide Association Study; Humans; Intensive Care Units; Iron; Iron Chelating Agents; Ketamine; Kidney; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Neoplasms; Neuroendocrine Tumors; Neurons; Nigella sativa; Obesity; Overweight; Oxidative Stress; Plant Extracts; Praziquantel; Pregnancy; Quality of Life; Radiometry; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Research Design; Retrospective Studies; RNA, Ribosomal, 23S; Schistosoma mansoni; Schistosomiasis; Schistosomiasis mansoni; Survivors; Vehicle Emissions | 2022 |
22 trial(s) available for deferoxamine and aluminum
| Article | Year |
|---|---|
Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.
Topics: Adult; Aged; Aluminum; Chelating Agents; Deferoxamine; Ferric Compounds; Hemosiderosis; Humans; Liver; Middle Aged; Mucormycosis; Organometallic Compounds; Renal Dialysis | 1992 |
Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis.
Topics: Adult; Aluminum; Charcoal; Deferoxamine; Female; Ferric Compounds; Hemoperfusion; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organometallic Compounds; Renal Dialysis | 1992 |
Haemofiltration or haemodialysis in aluminium elimination?
Topics: Aluminum; Deferoxamine; Evaluation Studies as Topic; Hemofiltration; Humans; Renal Dialysis | 1991 |
Desferrioxamine enhances the haemopoietic response to erythropoietin, but adverse events are common.
Topics: Adult; Aluminum; Chelation Therapy; Deferoxamine; Drug Therapy, Combination; Erythropoietin; Female; Hematopoiesis; Humans; Male; Middle Aged; Recombinant Proteins | 1991 |
Concomitant iron and aluminum mass transfer following deferoxamine infusion during hemofiltration.
Topics: Adult; Aluminum; Deferoxamine; Female; Ferritins; Hemofiltration; Humans; Iron; Male; Middle Aged; Uremia | 1991 |
Newcastle bone disease in Hong Kong: a study of aluminum associated osteomalacia.
Topics: Adult; Alkaline Phosphatase; Aluminum; Aluminum Hydroxide; Deferoxamine; Female; Fractures, Spontaneous; Hong Kong; Humans; Male; Multicenter Studies as Topic; Osteomalacia; Phosphates; Radiography; Renal Dialysis; Spectrophotometry, Atomic | 1990 |
Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers.
Topics: Aluminum; Deferoxamine; Humans; Membranes, Artificial; Polymers; Renal Dialysis; Sulfones | 1988 |
Clearance of aluminum by hemodialysis: effect of desferrioxamine.
Topics: Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Osteomalacia; Renal Dialysis | 1986 |
Efficacy of intramuscular and intraperitoneal deferoxamine for aluminum chelation.
Topics: Aluminum; Ascitic Fluid; Deferoxamine; Erythrocytes; Female; Humans; Injections, Intramuscular; Injections, Intraperitoneal; Male; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1987 |
Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
Topics: Adult; Aluminum; Anthropometry; Bone and Bones; Deferoxamine; Female; Humans; Male; Middle Aged; Minerals; Osteomalacia; Renal Dialysis | 1987 |
Aluminum removal by peritoneal dialysis: intravenous vs. intraperitoneal deferoxamine.
Topics: Adult; Aluminum; Complement System Proteins; Deferoxamine; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Microscopy, Fluorescence; Peritoneal Dialysis | 1986 |
Effect of desferrioxamine on removal of aluminum and iron by coated charcoal haemoperfusion and haemodialysis.
Topics: Adsorption; Aluminum; Charcoal; Clinical Trials as Topic; Deferoxamine; Hemoperfusion; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 1983 |
Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
Topics: Aluminum; Deferoxamine; Drug Administration Schedule; Humans; Renal Dialysis | 1994 |
[Aluminum poisoning in dialysis patients--diagnosis and therapy].
Topics: Adult; Aged; Aluminum; Deferoxamine; Female; Hemofiltration; Hemoperfusion; Humans; Male; Middle Aged; Poisoning; Renal Dialysis | 1994 |
Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum.
Topics: Aged; Aluminum; Alzheimer Disease; Behavior; Brain Chemistry; Deferoxamine; Female; Humans; Male; Middle Aged; Psychometrics; Single-Blind Method; Trace Elements; Videotape Recording | 1993 |
Treatment of aluminum overload using a cartridge with immobilized desferrioxamine.
Topics: Aluminum; Chromatography, Gel; Deferoxamine; Extracorporeal Circulation; Humans; Kidney Failure, Chronic; Renal Dialysis | 1995 |
Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload.
Topics: Adult; Aged; Aluminum; Bone Diseases; Deferoxamine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity | 1995 |
Low-dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated haemodialysis patients using two drug administration schedules.
Topics: Adult; Aged; Aged, 80 and over; Aluminum; Antidotes; Deferoxamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Middle Aged; Poisoning; Renal Dialysis | 1996 |
Efficacy of low-dose desferrioxamine for the estimation of aluminium overload in haemodialysis patients.
Topics: Adult; Aged; Aluminum; Antidotes; Deferoxamine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Renal Dialysis | 1996 |
Ultrafiltrable aluminium after very low doses of desferrioxamine.
Topics: Aged; Aluminum; Chelating Agents; Deferoxamine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Renal Dialysis; Ultrafiltration | 1998 |
Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients.
Topics: Adult; Aged; Aluminum; Deferoxamine; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Prospective Studies; Renal Dialysis | 2010 |
Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?
Topics: Administration, Oral; Aluminum; Aluminum Compounds; Deferoxamine; Dialysis Solutions; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Middle Aged; Osmosis; Phosphates; Renal Dialysis; Risk Assessment; Siderophores; Treatment Outcome | 2011 |
296 other study(ies) available for deferoxamine and aluminum
| Article | Year |
|---|---|
In vitro competition between ferrichrome and phage for the outer membrane T5 receptor complex of Escherichia coli.
Topics: Aluminum; Binding Sites; Binding, Competitive; Chromium; Coliphages; Deferoxamine; DNA Viruses; Escherichia coli; Ferrichrome; Hydroxamic Acids; Membranes; Peptides, Cyclic; Piperazines | 1975 |
Effects of isoproterenol and forskolin on carbachol- and fluoroaluminate-induced polyphosphoinositide hydrolysis, inositol trisphosphate production, and contraction in bovine iris sphincter smooth muscle: interaction between cAMP and IP3 second messenger
Topics: Aluminum; Animals; Carbachol; Cattle; Colforsin; Cyclic AMP; Deferoxamine; Fluorine; Hydrolysis; Inositol 1,4,5-Trisphosphate; Iris; Isoproterenol; Kinetics; Muscle Contraction; Muscle, Smooth; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Phosphorylation; Second Messenger Systems; Sodium Fluoride | 1992 |
Prurigo nodularis and aluminium overload in maintenance haemodialysis.
Topics: Adult; Aluminum; Deferoxamine; Humans; Male; Middle Aged; Prurigo; Renal Dialysis | 1992 |
Decrease of tumor-like calcification in uremia despite aggravation of secondary hyperparathyroidism: a case report.
Topics: Aluminum; Calcinosis; Chelation Therapy; Connective Tissue Diseases; Deferoxamine; Female; Humans; Hyperparathyroidism, Secondary; Middle Aged; Parathyroid Hormone; Radiography; Renal Dialysis; Shoulder; Uremia | 1992 |
Assessment of exposure to parenteral and oral aluminum with and without citrate using a desferrioxamine test in rats.
Topics: Absorption; Administration, Oral; Aluminum; Animal Feed; Animals; Body Burden; Citrates; Citric Acid; Deferoxamine; Environmental Exposure; Hematocrit; Injections, Intraperitoneal; Iron; Kidney; Liver; Male; Rats; Rats, Sprague-Dawley; Tibia | 1992 |
Assessment of renal osteodystrophy in hemodialysis patients.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Aluminum; Biopsy; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Clavicle; Deferoxamine; Female; Hand; Hemodialysis Units, Hospital; Humans; Kidney Failure, Chronic; Male; New York City; Phosphorus; Prospective Studies; Renal Dialysis; Sensitivity and Specificity | 1992 |
[Dialysis bone disease associated with other factors].
Topics: Aluminum; Amyloidosis; Bone Diseases, Metabolic; Calcium Carbonate; Deferoxamine; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 1992 |
[Aluminum and iron deposition in dialysis patients].
Topics: Aluminum; Anemia; Bone Diseases, Metabolic; Deferoxamine; Erythropoietin; Humans; Iron; Kidney Failure, Chronic; Metabolic Diseases; Recombinant Proteins; Renal Dialysis | 1992 |
Kinetics of aluminoxamine and feroxamine chelates in dialysis patients.
Topics: Adult; Aged; Aluminum; Chelating Agents; Deferoxamine; Humans; Iron; Kinetics; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1992 |
Aluminum-binding serum proteins: desferrioxamine alters serum aluminum speciation.
Topics: Adult; Aged; Albumins; Aluminum; Carrier Proteins; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Female; Humans; Male; Middle Aged; Occupational Exposure; Transferrin | 1992 |
Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients.
Topics: Aged; Aluminum; Bone Diseases; Deferoxamine; Evaluation Studies as Topic; Humans; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Renal Dialysis | 1992 |
Sucralfate-associated aluminum toxicity in a patient with renal failure: treatment with deferoxamine.
Topics: Adult; Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Sucralfate | 1992 |
Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease.
Topics: Adult; Aluminum; Biopsy; Bone and Bones; Bone Diseases, Metabolic; Deferoxamine; Diagnostic Errors; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis | 1992 |
Effect of body iron stores on serum aluminum level in hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aluminum; Aluminum Hydroxide; Anemia; Deferoxamine; Female; Ferritins; Humans; Iron; Male; Middle Aged; Renal Dialysis; Transferrin | 1992 |
Aluminum toxicity.
Topics: Aluminum; Anemia; Animals; Deferoxamine; Dementia; Disease Models, Animal; Humans; Kidney Failure, Chronic; Renal Dialysis | 1991 |
Desferrioxamine for Alzheimer's disease.
Topics: Aluminum; Alzheimer Disease; Deferoxamine; Drinking; Humans | 1991 |
Aluminum and deferoxamine kinetics in CAPD.
Topics: Aluminum; Deferoxamine; Humans; Peritoneal Dialysis, Continuous Ambulatory; Poisoning | 1991 |
[Speech apraxia in dialysis-associated aluminum encephalopathy].
Topics: Aluminum; Apraxias; Chelation Therapy; Deferoxamine; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Stuttering | 1991 |
Stimulation of prostaglandin synthesis in rabbit gastric antral mucosal slices by desferrioxamine in vitro.
Topics: Aluminum; Animals; Deferoxamine; Free Radicals; Gastric Mucosa; In Vitro Techniques; Iron; Kinetics; Lipid Peroxidation; Male; Prostaglandins; Pyloric Antrum; Rabbits | 1991 |
Removal of trace metals by continuous ambulatory peritoneal dialysis after desferrioxamine B chelation therapy.
Topics: Adult; Aluminum; Chelation Therapy; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Osteomalacia; Peritoneal Dialysis, Continuous Ambulatory; Trace Elements | 1991 |
Aluminium determination in the skin of patients with and without end-stage renal failure.
Topics: Adult; Aged; Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Skin | 1991 |
[A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient].
Topics: Adult; Aluminum; Deferoxamine; Female; Ferritins; Humans; Infusions, Intravenous; Iron; Osteomalacia; Renal Dialysis; Serum Albumin | 1991 |
Desferrioxamine infusion can modify EEG tracing in haemodialysed patients.
Topics: Aluminum; Brain; Deferoxamine; Electroencephalography; Humans; Infusions, Intravenous; Middle Aged; Renal Dialysis | 1991 |
Aluminum salts stimulate luminol-enhanced chemiluminescence production by human neutrophils.
Topics: Alum Compounds; Aluminum; Aluminum Chloride; Aluminum Compounds; Azides; Chlorides; Cytochalasin B; Deferoxamine; Edetic Acid; Ferric Compounds; Humans; Luminescent Measurements; Luminol; Neutrophils; Pentetic Acid; Sodium Azide | 1991 |
Low-dose desferrioxamine test for the diagnosis of aluminium-related bone disease in patients on regular haemodialysis.
Topics: Adult; Aluminum; Bone Diseases; Deferoxamine; Diagnostic Errors; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Renal Dialysis | 1991 |
Comment on "Irreversible ocular toxicity from single challenge dose of desferrioxamine" by C. Bene et al.
Topics: Aluminum; Deferoxamine; Eye; Humans; Renal Dialysis | 1991 |
[The causes of aluminum cumulation and poisoning in patients with chronic kidney failure treated by hemodialysis on a regular program and the possibilities for therapy].
Topics: Aluminum; Aluminum Hydroxide; Calcium Carbonate; Deferoxamine; Hemodialysis Solutions; Hemofiltration; Humans; Kidney Failure, Chronic; Poisoning; Renal Dialysis; Time Factors | 1991 |
Erythropoietin, aluminium, and anaemia in patients on haemodialysis.
Topics: Adult; Aluminum; Anemia, Hypochromic; Deferoxamine; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Erythrocyte Count; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Ferrochelatase; Humans; Hydroxymethylbilane Synthase; Lyases; Male; Middle Aged; Protoporphyrins; Recombinant Proteins; Renal Dialysis | 1990 |
Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.
Topics: Aluminum; Anemia; Deferoxamine; Erythropoietin; Humans; Renal Dialysis; Time Factors | 1990 |
Case management of the anemic patient epoetin alfa: focus on aluminum management.
Topics: Adult; Aged; Aluminum; Anemia; Deferoxamine; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Male; Poisoning | 1991 |
Aluminum mobilization by desferrioxamine assessed by microdialysis of the blood, liver and brain.
Topics: Aluminum; Animals; Brain; Brain Chemistry; Chelation Therapy; Deferoxamine; Dialysis; Injections, Intraperitoneal; Kinetics; Liver; Male; Rats; Rats, Inbred Strains; Spectrophotometry, Atomic | 1991 |
Deferoxamine and aluminum clearance in pediatric hemodialysis patients.
Topics: Aluminum; Charcoal; Child; Deferoxamine; Female; Hemoperfusion; Humans; Male; Metabolic Clearance Rate; Renal Dialysis | 1991 |
Treatment with deferoxamine: a real risk factor for mucormycosis?
Topics: Aluminum; Deferoxamine; Dialysis; Humans; Injections, Intramuscular; Iron; Male; Middle Aged; Mucormycosis; Rhizopus; Risk Factors | 1991 |
Red blood cell aluminum in patients with renal failure and effect of desferrioxamine infusion.
Topics: Adult; Aged; Aluminum; Chelation Therapy; Deferoxamine; Erythrocytes; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Ultrafiltration | 1990 |
Aluminium interference in the treatment with recombinant human erythropoietin.
Topics: Aluminum; Anemia; Deferoxamine; Drug Resistance; Erythropoietin; Humans; Recombinant Proteins; Uremia | 1990 |
Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
Topics: Aluminum; Bone and Bones; Deferoxamine; Female; Humans; Hyperparathyroidism; Iron; Long-Term Care; Male; Middle Aged; Parathyroid Hormone; Prospective Studies; Renal Dialysis | 1990 |
Aluminium interference in the treatment of haemodialysis patients with recombinant human erythropoietin.
Topics: Adult; Aluminum; Anemia; Deferoxamine; Erythropoietin; Humans; Middle Aged; Recombinant Proteins; Renal Dialysis | 1990 |
The behavior of the ouabain-insensitive sodium efflux in single barnacle muscle fibers toward the microinjection of aluminum.
Topics: Aluminum; Animals; Cadmium; Calcium; Deferoxamine; Egtazic Acid; Gallium; In Vitro Techniques; Magnesium; Microinjections; Muscles; Ouabain; Ryanodine; Scandium; Sodium; Thoracica; Verapamil | 1990 |
Removal of chelated aluminium during haemodialysis using polysulphone high-flux dialysers.
Topics: Aluminum; Charcoal; Deferoxamine; Dialysis Solutions; Hemoperfusion; Humans; Metabolic Clearance Rate; Polymers; Renal Dialysis; Sulfones | 1990 |
Acute visual disorders in patients on regular dialysis given desferrioxamine as a test.
Topics: Aged; Aluminum; Deferoxamine; Eye; Female; Humans; Male; Middle Aged; Ocular Physiological Phenomena; Optic Nerve; Renal Dialysis; Vision Disorders; Visual Acuity | 1990 |
Differential activation of the stimulatory and inhibitory guanine nucleotide-binding proteins by fluoroaluminate in cells and in membranes.
Topics: Adenylate Cyclase Toxin; Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Calcium; Cell Line; Cell Membrane; Cell Membrane Permeability; Chlorides; Chorionic Gonadotropin; Cyclic AMP; Deferoxamine; Dibutyryl Cyclic GMP; Fluorine; GTP-Binding Proteins; Humans; Kinetics; Pertussis Toxin; Phosphatidic Acids; Sodium Fluoride; Theophylline; Virulence Factors, Bordetella | 1990 |
What treatment would you advise for a 1-year-old child with chronic renal failure who has been on aluminum hydroxide as a phosphate binder for 6 months and then develops epilepsy and is found to have a grossly raised plasma aluminum concentration?
Topics: Aluminum; Aluminum Hydroxide; Deferoxamine; Epilepsy; Humans; Infant; Kidney Failure, Chronic | 1990 |
[Comparison of the effectiveness of hemodialysis and hemofiltration in the removal of aluminum from the body].
Topics: Aluminum; Deferoxamine; Dialysis Solutions; Hemofiltration; Humans; Renal Dialysis | 1990 |
[The diagnostic critical value in DFO low dose loading test on patient with aluminum accumulation compared to each parameter of ROD].
Topics: Adolescent; Adult; Aged; Aluminum; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Male; Middle Aged; Predictive Value of Tests | 1990 |
[High deposition rate of aluminum in tissues in diabetic hemodialysis patients].
Topics: Adult; Aged; Aluminum; Deferoxamine; Diabetic Nephropathies; Female; Glomerulonephritis; Humans; Male; Middle Aged; Renal Dialysis; Tissue Distribution | 1990 |
Suppression of deferoxamine mesylate treatment-induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation.
Topics: Aluminum; Alzheimer Disease; Chelation Therapy; Chromatography, High Pressure Liquid; Deferoxamine; Drug Therapy, Combination; Humans; Injections, Intramuscular; Isoniazid; Monoamine Oxidase; Pyridoxine | 1990 |
Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine.
Topics: Adult; Aged; Aged, 80 and over; Aluminum; Chelation Therapy; Deferoxamine; Female; Hearing Loss, Bilateral; Hearing Loss, Sensorineural; Humans; Iron; Male; Middle Aged; Prospective Studies; Renal Dialysis; Retinal Diseases; Vision Disorders | 1990 |
The role of aluminum in the functional iron deficiency of patients treated with erythropoietin: case report of clinical characteristics and response to treatment.
Topics: Aluminum; Anemia; Biological Availability; Deferoxamine; Erythropoiesis; Erythropoietin; Female; Humans; Iron; Iron Deficiencies; Kidney Failure, Chronic; Middle Aged; Recombinant Proteins; Renal Dialysis | 1990 |
Altered biodistribution of gallium-67 in a patient with aluminum toxicity treated with desferoxamine.
Topics: Aged; Aluminum; Citrates; Citric Acid; Deferoxamine; Drug Interactions; Gallium Radioisotopes; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Tissue Distribution | 1990 |
Aluminum removal in uremic patients after desferrioxamine infusion: is hemofiltration more effective than hemodialysis?
Topics: Aluminum; Deferoxamine; Hemofiltration; Humans; Infusions, Parenteral; Renal Dialysis; Uremia | 1990 |
Prospective evaluation of aluminum loading from formula in infants with uremia.
Topics: Aluminum; Bone and Bones; Deferoxamine; Dialysis Solutions; Follow-Up Studies; Histocytochemistry; Humans; Infant; Infant Food; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Spectrophotometry, Atomic; Tissue Distribution; Uremia | 1990 |
Hyperparathyroidism after aluminum depletion.
Topics: Aluminum; Deferoxamine; Humans; Hyperparathyroidism; Parathyroid Hormone; Renal Dialysis | 1990 |
Deferoxamine for aluminum toxicity in dialysis patients.
Topics: Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic | 1990 |
Cerebrospinal fluid aluminum levels following deferoxamine.
Topics: Adult; Aluminum; Brain Diseases; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Renal Dialysis | 1990 |
High performance liquid chromatography methods for studying protein binding of aluminium in human serum in the absence and in the presence of desferrioxamine.
Topics: Aluminum; Chelating Agents; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Deferoxamine; Fluorometry; Humans; Protein Binding; Serum Albumin; Transferrin | 1990 |
Silicon measurement in serum and urine by direct current plasma emission spectrometry.
Topics: Aluminum; Calcium; Creatine; Deferoxamine; Diet; Dose-Response Relationship, Drug; Humans; Kidney Calculi; Kidney Failure, Chronic; Renal Dialysis; Silicon | 1990 |
Trace elements and complications in patients undergoing chronic hemodialysis.
Topics: Aluminum; Anemia; Deferoxamine; Female; Hematocrit; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Manganese; Middle Aged; Nickel; Reference Values; Renal Dialysis; Silicon; Spectrophotometry, Atomic; Trace Elements; Zinc | 1990 |
Bone histologic response to deferoxamine in aluminum-related bone disease.
Topics: Aluminum; Bone and Bones; Bone Diseases; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Osteoblasts; Osteoclasts; Parathyroid Hormone; Renal Dialysis; Staining and Labeling | 1987 |
Exacerbation of aluminium encephalopathy after treatment with desferrioxamine.
Topics: Aluminum; Brain Diseases; Deferoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1989 |
Hypocalcemia complicating deferoxamine therapy in an infant with parenteral nutrition-associated aluminum overload: evidence for a role of aluminum in the bone disease of infants.
Topics: Adult; Aluminum; Bone Diseases, Metabolic; Calcium; Deferoxamine; Female; Humans; Hypocalcemia; Infant; Parenteral Nutrition, Total | 1989 |
Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Beneficial effects of desferrioxamine.
Topics: Aluminum; Bacterial Infections; Deferoxamine; Disease Susceptibility; Ferritins; Humans; Iron; Renal Dialysis | 1989 |
Clinical and histological results of long-term management of aluminium overloading in uraemic patients with desferrioxamine.
Topics: Adult; Aluminum; Bone and Bones; Chelation Therapy; Deferoxamine; Electroencephalography; Female; Follow-Up Studies; Humans; Iron; Metals; Middle Aged; Pain; Poisoning; Time Factors; Uremia | 1989 |
Desferrioxamine content of aluminum.
Topics: Aluminum; Deferoxamine; Drug Contamination; Humans; Sodium Chloride | 1989 |
Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity.
Topics: Adult; Aluminum; Aluminum Hydroxide; Deferoxamine; Dihydropteridine Reductase; Drug Evaluation; Erythrocytes; Evoked Potentials, Visual; Female; Humans; Long-Term Care; Male; Middle Aged; NADH, NADPH Oxidoreductases; Psychological Tests; Psychomotor Performance; Random Allocation; Reading; Renal Dialysis; Vision Tests | 1989 |
Short-term effects of parathyroidectomy on plasma biochemistry in chronic uremia.
Topics: Alkaline Phosphatase; Aluminum; Bone and Bones; Calcifediol; Calcium; Chronic Disease; Cohort Studies; Deferoxamine; gamma-Glutamyltransferase; Humans; Hyperparathyroidism, Secondary; Osteocalcin; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Uremia | 1989 |
Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis.
Topics: Aluminum; Anemia; Deferoxamine; Hematopoiesis; Hemoglobins; Humans; Kidney Failure, Chronic; Prospective Studies; Renal Dialysis | 1989 |
The role of aluminum in the pathogenesis of anemia in an outpatient hemodialysis population.
Topics: Aluminum; Ambulatory Care; Anemia; Biomarkers; Deferoxamine; Erythrocytes; Female; Humans; Male; Regression Analysis; Renal Dialysis | 1989 |
[Detecting and evaluating hyperaluminemia in 3 dialysis centers].
Topics: Aluminum; Deferoxamine; Dialysis Solutions; Humans; Osteomalacia; Renal Dialysis | 1989 |
Clearance of aluminium desferrioxamine by haemodialysis using a polysulfone high flux membrane.
Topics: Aluminum; Calibration; Cellulose; Chelation Therapy; Creatinine; Deferoxamine; Humans; Membranes, Artificial; Organometallic Compounds; Polymers; Renal Dialysis; Sulfones; Urea | 1989 |
Plasma aluminum levels (unstimulated and stimulated): clinical and biochemical findings in 185 patients undergoing chronic hemodialysis for 4 to 95 months.
Topics: Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Osteomalacia; Renal Dialysis; Time Factors | 1989 |
Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients.
Topics: Aluminum; Charcoal; Deferoxamine; Hemoperfusion; Humans; Kidneys, Artificial; Renal Dialysis | 1989 |
Prevention and treatment of aluminum overload in uremic patients: long-term results.
Topics: Adult; Aluminum; Deferoxamine; Dialysis Solutions; Female; Humans; Male; Middle Aged; Uremia | 1989 |
[Efficacy and safety of long-term and low-dose desferrioxamine therapy against hyperaluminemia and the clinical symptoms associated with hyperaluminemia in patients undergoing maintenance hemodialysis].
Topics: Adult; Aluminum; Deferoxamine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Dialysis; Time Factors | 1989 |
Deferoxamine test and bone disease in dialysis patients with mild aluminum accumulation.
Topics: Aluminum; Biopsy; Bone and Bones; Deferoxamine; Dialysis; Humans; Osteomalacia; Prospective Studies; Time Factors | 1989 |
Reversal of an aluminum-induced behavioral deficit by administration of deferoxamine.
Topics: Alum Compounds; Aluminum; Animals; Avoidance Learning; Deferoxamine; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Motor Activity; Rats; Rats, Inbred Strains | 1989 |
Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
Topics: Aluminum; Bone and Bones; Bone Diseases; Calcium; Deferoxamine; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Osteomalacia; Parathyroid Glands; Renal Dialysis | 1989 |
Aluminum-binding protein in dialysis dementia. II. Characterization in plasma by ultrafiltration.
Topics: Aluminum; Carrier Proteins; Deferoxamine; Dementia; Humans; Molecular Weight; Renal Dialysis; Ultrafiltration | 1989 |
Vitamin D, desferrioxamine and aluminum-induced bone disease in uremic rats.
Topics: Aluminum; Animals; Bone and Bones; Brain Chemistry; Chronic Kidney Disease-Mineral and Bone Disorder; Creatinine; Deferoxamine; Liver; Male; Muscles; Rats; Rats, Inbred Strains; Uremia; Vitamin D | 1989 |
Irreversible ocular toxicity from single "challenge" dose of deferoxamine.
Topics: Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Macular Edema; Middle Aged; Optic Nerve Diseases; Peritoneal Dialysis, Continuous Ambulatory; Retinal Pigments; Vision, Low | 1989 |
Clinical aspects and applications of hemofiltration.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Aluminum; Bone and Bones; Calcium-Binding Proteins; Cefuroxime; Child; Child, Preschool; Deferoxamine; Female; Hemofiltration; Hemoperfusion; Humans; Male; Metabolic Clearance Rate; Middle Aged; Organometallic Compounds; Osteocalcin; Parathyroid Hormone; Renal Dialysis | 1989 |
Aluminium bone deposits in normal renal function patients after long-term treatment by plasma exchange.
Topics: Aged; Aluminum; Biopsy; Bone and Bones; Deferoxamine; Female; Humans; Kidney; Middle Aged; Osteomalacia; Plasma Exchange; Time Factors | 1989 |
AlF4- reversibly inhibits 'P'-type cation-transport ATPases, possibly by interacting with the phosphate-binding site of the ATPase.
Topics: Adenosine Triphosphatases; Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Beryllium; Binding Sites; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Cell Membrane; Chlorides; Deferoxamine; Fluorides; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Guanylyl Imidodiphosphate; Isoenzymes; Magnesium; Magnesium Chloride; Nitrophenols; Organophosphorus Compounds; Phosphates; Sodium Fluoride; Sodium-Potassium-Exchanging ATPase; Swine; Thionucleotides | 1988 |
Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts.
Topics: alpha-Linolenic Acid; Aluminum; Animals; Cations; Cattle; Deferoxamine; Edetic Acid; Erythrocyte Membrane; Ferrous Compounds; Humans; Hydrogen-Ion Concentration; Iron; Linolenic Acids; Lipid Peroxides; Liposomes; Membrane Lipids; Micelles; Pentetic Acid | 1985 |
Aluminium-related bone disease and haemodialysis.
Topics: Aluminum; Bone and Bones; Bone Diseases; Deferoxamine; Humans; Renal Dialysis | 1987 |
Aluminium chelation therapy in dialysis patients: evidence for inhibition of haemoglobin synthesis by low levels of aluminium.
Topics: Adult; Aluminum; Anemia; Deferoxamine; Erythrocyte Indices; Female; Ferritins; Hemoglobins; Humans; Male; Middle Aged; Renal Dialysis; Serum Albumin | 1988 |
Anaemia and aluminium chelation therapy in dialysis patients.
Topics: Aluminum; Anemia; Deferoxamine; Humans; Renal Dialysis | 1988 |
Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
Topics: Aluminum; Anemia; Deferoxamine; Erythrocytes; Ferritins; Humans; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1989 |
Aluminum removal after chronic intoxication in rats.
Topics: Aluminum; Animals; Bone and Bones; Chronic Disease; Deferoxamine; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1989 |
[Chronic aluminum poisoning in continuous ambulatory peritoneal dialysis: treatment with deferoxamine].
Topics: Aluminum; Chronic Disease; Deferoxamine; Female; Humans; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Time Factors | 1989 |
Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.
Topics: Aluminum; Charcoal; Deferoxamine; Hemodialysis Solutions; Hemofiltration; Hemoperfusion; Humans; Infusions, Parenteral; Renal Dialysis; Solutions; Uremia | 1989 |
Aluminum toxicity complicating renal osteodystrophy. A case report.
Topics: Aluminum; Bone and Bones; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Combined Modality Therapy; Deferoxamine; Fracture Fixation, Internal; Fractures, Spontaneous; Humans; Male; Osteotomy; Radiography | 1989 |
[Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
Topics: Adult; Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Osteomalacia; Renal Dialysis; Time Factors | 1986 |
The effect of desferrioxamine on tissue aluminum concentration and bone histology in aluminum-loaded rats with renal failure.
Topics: Aluminum; Animals; Bone Diseases; Deferoxamine; Disease Models, Animal; Kidney Failure, Chronic; Male; Poisoning; Random Allocation; Rats; Rats, Inbred Strains; Tissue Distribution | 1988 |
Effects of aluminum(III), chromium(III), and iron(III) on the rate of dissolution of calcium hydroxyapatite crystals in the absence and presence of the chelating agent desferrioxamine.
Topics: Adsorption; Aluminum; Aluminum Chloride; Aluminum Compounds; Chlorides; Chromium; Chromium Compounds; Crystallization; Deferoxamine; Durapatite; Ferric Compounds; Humans; Hydroxyapatites; Nitrates; Solubility; Solutions | 1987 |
Desferrioxamine infusion test.
Topics: Aluminum; Deferoxamine; Humans; Renal Dialysis | 1987 |
The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
Topics: Adult; Aluminum; Deferoxamine; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Osteomalacia; Peritoneal Dialysis, Continuous Ambulatory | 1987 |
The stimulation by sodium fluoride of plasma-membrane Ca2+ inflow in isolated hepatocytes. Evidence that a GTP-binding regulatory protein is involved in the hormonal stimulation of Ca2+ inflow.
Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Biological Transport; Calcium; Cell Membrane; Chlorides; Deferoxamine; GTP-Binding Proteins; In Vitro Techniques; Liver; Male; Phosphorylases; Protein Kinase C; Sodium Fluoride; Vasopressins | 1987 |
Improvement of anaemia with desferrioxamine in haemodialysis patients.
Topics: Adult; Aluminum; Anemia; Blood Transfusion; Deferoxamine; Female; Hematocrit; Hemosiderosis; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1987 |
Desferrioxamine infusion test.
Topics: Aluminum; Deferoxamine; Humans; Infusions, Intra-Arterial; Renal Dialysis | 1987 |
The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro.
Topics: Aluminum; Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Ascorbic Acid; Calcimycin; Deferiprone; Deferoxamine; Epinephrine; Epoprostenol; Hydrogen Peroxide; Iron; Iron Chelating Agents; Male; Pyridones; Rats; Rats, Inbred Strains | 1988 |
Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients.
Topics: Adult; Aluminum; Body Burden; Cognition Disorders; Deferoxamine; Female; Humans; Male; Middle Aged; Neuromuscular Diseases; Prospective Studies; Renal Dialysis; Time Factors | 1988 |
Treatment and histological healing of aluminum-related osteomalacia.
Topics: Adult; Aluminum; Calcium; Deferoxamine; Female; Hemodialysis Solutions; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Osteomalacia | 1988 |
Deferoxamine for the diagnosis and treatment of aluminum-associated osteodystrophy.
Topics: Adult; Aluminum; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Infusions, Intravenous; Male; Parathyroid Hormone; Renal Dialysis | 1988 |
Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients.
Topics: Aluminum; Charcoal; Deferoxamine; Hemoperfusion; Humans; In Vitro Techniques; Renal Dialysis | 1988 |
Rapid conversion from aluminium bone disease to hyperparathyroid bone disease by desferrioxamine.
Topics: Adult; Aluminum; Bone Diseases; Deferoxamine; Female; Fractures, Spontaneous; Humans; Hyperparathyroidism; Hyperplasia; Osteomalacia; Parathyroid Glands; Pubic Bone; Renal Dialysis; Rib Fractures | 1988 |
Microcytic anemia in dialysis patients.
Topics: Aluminum; Anemia; Deferoxamine; Humans; Renal Dialysis | 1988 |
Speciation studies of serum aluminum/citrate complex by liquid chromatography-furnace AAS.
Topics: Aluminum; Chromatography, Gel; Chromatography, Liquid; Citrates; Citric Acid; Deferoxamine; Humans; Protein Binding; Spectrophotometry, Atomic; Uremia | 1988 |
Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Aluminum; Chelating Agents; Deferoxamine; Humans; Iron; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory | 1988 |
Determination of desferrioxamine B, its complexes with iron and aluminium and selected derivatives by high-performance liquid chromatography using a polymer column.
Topics: Aluminum; Chromatography, High Pressure Liquid; Deferoxamine; Indicators and Reagents; Iron; Polymers | 1988 |
Citric, malic and succinic acids as possible alternatives to deferoxamine in aluminum toxicity.
Topics: Aluminum; Animals; Brain Chemistry; Citrates; Citric Acid; Deferoxamine; Feces; Injections, Intraperitoneal; Kidney; Liver; Malates; Male; Mice; Succinates; Succinic Acid | 1988 |
[The deferoxamine loading test as a non-invasive method for diagnosing Al-related bone disease in hemodialysis patients; efficacy of deferoxamine therapy for the disease].
Topics: Adolescent; Adult; Aged; Aluminum; Bone Diseases; Deferoxamine; Female; Humans; Male; Middle Aged; Renal Dialysis | 1988 |
Correlation between serum aluminum concentration and signs of encephalopathy in a large population of patients dialyzed with aluminum-free fluids.
Topics: Aluminum; Brain Diseases; Deferoxamine; Electroencephalography; Female; Humans; Male; Middle Aged; Neurologic Examination; Peritoneal Dialysis, Continuous Ambulatory; Psychological Tests; Renal Dialysis; Risk Factors; Syndrome | 1988 |
Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease.
Topics: Adult; Aluminum; Bone Diseases; Deferoxamine; Dementia; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1988 |
Toxic effects of aluminum in end-stage renal disease: discussion of a case.
Topics: Aluminum; Bone Diseases, Metabolic; Brain Diseases; Deferoxamine; Female; Hemodialysis, Home; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged | 1988 |
Effect of aluminum and deferoxamine on biliary iron elimination in the rat.
Topics: Aluminum; Animals; Bile; Deferoxamine; Iron; Male; Organometallic Compounds; Rats; Rats, Inbred Strains | 1988 |
Determination of aluminium in serum by atomic absorption spectrometry with the L'vov platform at different resonance lines.
Topics: Aluminum; Deferoxamine; Humans; Renal Dialysis; Spectrophotometry, Atomic; Uremia | 1987 |
[Aluminum-induced osteomalacia in chronic hemodialysis].
Topics: Aluminum; Child, Preschool; Deferoxamine; Female; Humans; Osteomalacia; Parathyroid Glands; Postoperative Complications; Renal Dialysis | 1987 |
Pharmacokinetics of desferrioxamine and of its iron and aluminium chelates in patients on haemodialysis.
Topics: Adult; Aluminum; Deferoxamine; Female; Humans; Iron; Kidney Failure, Chronic; Male; Microchemistry; Middle Aged; Renal Dialysis | 1987 |
Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
Topics: Adult; Aluminum; Biopsy; Bone and Bones; Deferoxamine; Humans; Male; Osteomalacia; Renal Dialysis | 1987 |
Aluminum an uremic toxin.
Topics: Aluminum; Deferoxamine; Humans; Renal Dialysis; Tissue Distribution; Toxins, Biological; Uremia | 1987 |
Role of desferrioxamine in the treatment of dialysis encephalopathy.
Topics: Adult; Aged; Aluminum; Brain Diseases; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1986 |
Changes in bone histology after treatment with desferrioxamine.
Topics: Adolescent; Adult; Aluminum; Bone and Bones; Deferoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Osteomalacia; Renal Dialysis | 1986 |
Aluminum intoxication of bone in renal failure--fact or fiction?
Topics: Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Osteomalacia; Renal Dialysis | 1986 |
Clinical and biochemical features of aluminum-related bone disease.
Topics: Adolescent; Adult; Aged; Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Osteomalacia; Radiography; Renal Dialysis; Water Supply | 1986 |
Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
Topics: Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Osteomalacia; Parathyroid Hormone; Renal Dialysis | 1986 |
Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.
Topics: Adolescent; Adult; Aged; Aluminum; Bone and Bones; Bone Diseases; Bone Resorption; Child; Child, Preschool; Cross-Sectional Studies; Deferoxamine; Female; Humans; Longitudinal Studies; Male; Middle Aged; Minerals; Osteoblasts; Osteogenesis; Renal Dialysis; Retrospective Studies | 1986 |
The interaction of parathyroid hormone and aluminum in renal osteodystrophy.
Topics: Adult; Aluminum; Calcium Carbonate; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Humans; Male; Osteomalacia; Parathyroid Hormone; Phosphates; Renal Dialysis | 1987 |
[Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine].
Topics: Adult; Aluminum; Deferoxamine; Female; Humans; Osteomalacia; Renal Dialysis | 1986 |
Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
Topics: Adult; Aluminum; Bone Diseases, Metabolic; Deferoxamine; Female; Humans; Male; Middle Aged; Osteomalacia; Parathyroid Hormone; Renal Dialysis; Tetracycline | 1987 |
Mucormycosis--a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload?
Topics: Adult; Aluminum; Deferoxamine; Humans; Iron; Male; Mucormycosis; Renal Dialysis | 1987 |
Serum aluminum levels and erythrocyte dihydropteridine reductase activity in patients on hemodialysis.
Topics: Adult; Aluminum; Biopterins; Deferoxamine; Dihydropteridine Reductase; Erythrocytes; Humans; Middle Aged; NADH, NADPH Oxidoreductases; Renal Dialysis | 1987 |
[Severe ocular toxicity of desferrioxamine in the hemodialyzed patient].
Topics: Aged; Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Retinitis Pigmentosa; Vision Disorders | 1987 |
Aluminum-associated bone disease: considerations on the pathogenesis and the effects of deferoxamine treatment.
Topics: Aluminum; Bone Diseases; Calcium; Deferoxamine; Humans; Osteoblasts; Renal Dialysis | 1987 |
Deferoxamine (DFO): the effectiveness for noninvasive diagnosis of aluminum-related bone disease, and for treatment of the disease.
Topics: Aluminum; Bone and Bones; Bone Diseases; Calcitriol; Calcium; Deafness; Deferoxamine; Eye; Humans; Renal Dialysis; Uremia | 1987 |
Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis.
Topics: Adult; Aluminum; Deferoxamine; Female; Ferric Compounds; Hemochromatosis; Humans; Injections, Intramuscular; Iron; Kinetics; Male; Middle Aged; Organometallic Compounds | 1987 |
Deferoxamine use in aluminum toxicity.
Topics: Aluminum; Brain Diseases; Deferoxamine; Female; Humans; Middle Aged; Renal Dialysis | 1986 |
Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine.
Topics: Adult; Aged; Aluminum; Deferoxamine; Encephalitis; Female; Hemosiderosis; Humans; Male; Middle Aged; Mucormycosis; Opportunistic Infections; Renal Dialysis; Rhizopus | 1987 |
Aluminum accumulation in children on chronic dialysis: predictive value of serum aluminum levels and desferrioxamine infusion test.
Topics: Adolescent; Aluminum; Bone and Bones; Child; Child, Preschool; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Renal Dialysis | 1987 |
The response of the normochromic normocytic anaemia of chronic renal failure to desferrioxamine.
Topics: Adult; Aged; Aluminum; Anemia; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged | 1987 |
Assessment of potential aluminum chelators in an octanol/aqueous system and in the aluminum-loaded rabbit.
Topics: Aluminum; Animals; Carboxylic Acids; Chelating Agents; Deferoxamine; Dioxanes; Models, Biological; Octanols; Rabbits; Structure-Activity Relationship; Tetracycline; Thermodynamics; Water | 1987 |
[Treatment of aluminum-induced osteopathy with desferrioxamine in dialysis-dependent renal failure].
Topics: Adult; Aluminum; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1987 |
Affinity of the aluminium binding protein.
Topics: Aluminum; Deferoxamine; Dialysis; Humans; In Vitro Techniques; Protein Binding; Ultrafiltration | 1986 |
Biliary excretion of aluminum in aluminum osteodystrophy with liver disease.
Topics: Adult; Aluminum; Aluminum Hydroxide; Bile; Bone and Bones; Bone Diseases, Metabolic; Chronic Disease; Deferoxamine; Female; Humans; Liver Diseases | 1986 |
Estimation of aluminoxamine and ferrioxamine in plasma by high performance liquid chromatography.
Topics: Aluminum; Chromatography, High Pressure Liquid; Deferoxamine; Ferric Compounds; Humans; Iron; Kidney Failure, Chronic; Organometallic Compounds; Peritoneal Dialysis, Continuous Ambulatory | 1986 |
Treatment of aluminum toxicity in infantile uremia with deferoxamine.
Topics: Aluminum; Bone and Bones; Deferoxamine; Humans; Infant; Male; Peritoneal Dialysis; Uremia | 1986 |
Removal of aluminum during hemodialysis: effect of different dialyzer membranes.
Topics: Acrylic Resins; Adult; Aged; Aluminum; Cellulose; Deferoxamine; Humans; Kidneys, Artificial; Membranes, Artificial; Middle Aged | 1986 |
Combined hemofiltration and desferrioxamine treatment for aluminum induced osteomalacia.
Topics: Aluminum; Blood; Deferoxamine; Humans; Male; Middle Aged; Osteomalacia; Renal Dialysis; Ultrafiltration | 1986 |
Indirect micro-scale method for the determination of desferrioxamine and its aluminium and iron chelated forms in biological samples by atomic absorption spectrometry with electrothermal atomisation.
Topics: Aluminum; Chelating Agents; Deferoxamine; Electrochemistry; Humans; Iron; Spectrophotometry, Atomic | 1986 |
The effect of desferrioxamine on concentration and distribution of aluminum in bone.
Topics: Aluminum; Animals; Bone and Bones; Calcification, Physiologic; Deferoxamine; Kidney; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1986 |
Acute aluminium intoxication: a study of the efficacy of several antidotal treatments in mice.
Topics: Aluminum; Animals; Chelating Agents; Citrates; Citric Acid; Cysteine; Deferoxamine; Lethal Dose 50; Male; Mice; Sodium Salicylate; Tissue Distribution | 1986 |
[Aluminum associated bone disease in patients undergoing long-term hemodialysis].
Topics: Adult; Aluminum; Bone and Bones; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Hydroxycholecalciferols; Male; Middle Aged; Renal Dialysis; Uremia | 1986 |
Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine.
Topics: Aluminum; Anemia, Hypochromic; Chelating Agents; Deferoxamine; Humans; Infant; Kidney Failure, Chronic; Male; Osteomalacia; Peritoneal Dialysis | 1986 |
Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
Topics: Aluminum; Deferoxamine; Dementia; Female; Humans; Kidney Failure, Chronic; Middle Aged; Myoclonus; Renal Dialysis; Seizures | 1986 |
Evidence for a cutoff value of desferrioxamine infusion test for bone aluminium deposits in hemodialyzed patients.
Topics: Aluminum; Bone and Bones; Deferoxamine; Humans; Renal Dialysis | 1986 |
Trace metals and degenerative diseases of the skeleton.
Topics: Aluminum; Bone Diseases; Deferoxamine; Humans; Renal Dialysis; Tissue Distribution | 1986 |
Copper removal from renal patients using desferrioxamine chelation to reduce aluminium overload.
Topics: Aluminum; Bone and Bones; Bone Marrow; Copper; Deferoxamine; Humans; Kidney Failure, Chronic; Renal Dialysis | 1986 |
The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia.
Topics: Aluminum; Aluminum Chloride; Aluminum Compounds; Animals; Bone and Bones; Chlorides; Deferoxamine; Drug Evaluation, Preclinical; Female; Minerals; Osteomalacia; Rats; Rats, Inbred Strains; Renal Dialysis; Time Factors | 1986 |
High bone turnover associated with an aluminum-induced impairment of bone mineralization.
Topics: Aluminum; Biopsy; Bone and Bones; Bone Diseases, Metabolic; Deferoxamine; Humans; Hyperparathyroidism; Male; Middle Aged; Minerals; Renal Dialysis | 1986 |
Alterations in inositol phosphate production during oxidative stress in isolated hepatocytes.
Topics: Adenosine Triphosphate; Aluminum; Aluminum Chloride; Aluminum Compounds; Angiotensin II; Animals; Calcium; Chlorides; Deferoxamine; Dithiothreitol; Epinephrine; Inositol Phosphates; Liver; Male; Oxidation-Reduction; Rats; Rats, Inbred Strains; Sodium Fluoride; Sugar Phosphates; Vitamin K | 1987 |
Early deposition of aluminum in bone in diabetic patients on hemodialysis.
Topics: Aluminum; Bone and Bones; Bone Development; Deferoxamine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Renal Dialysis; Time Factors; Uremia | 1987 |
[Desferal treatment of aluminum poisoning; effect on serum concentrations of aluminum (Al), iron (Fe) and copper (Cu)].
Topics: Adult; Aluminum; Copper; Deferoxamine; Female; Glomerulonephritis; Humans; Hypertension, Renal; Iron; Male; Metabolic Clearance Rate; Renal Dialysis | 1986 |
Deferoxamine-enhanced fecal losses of aluminum and iron in a patient undergoing continuous ambulatory peritoneal dialysis.
Topics: Adult; Aluminum; Deferoxamine; Feces; Female; Hemosiderosis; Humans; Iron; Iron Deficiencies; Osteomalacia; Peritoneal Dialysis, Continuous Ambulatory; Transfusion Reaction | 1987 |
[Indications for desferrioxamine in patients with chronic renal insufficiency treated by dialysis].
Topics: Aluminum; Deferoxamine; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis | 1986 |
Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.
Topics: Adult; Aluminum; Anemia; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Erythrocyte Indices; Erythrocytes, Abnormal; Ferritins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Protoporphyrins; Renal Dialysis | 1987 |
Continuous ambulatory EEG monitoring following desferrioxamine (DFO) i.v. infusion.
Topics: Adult; Aluminum; Deferoxamine; Electroencephalography; Female; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1985 |
Desferrioxamine in the treatment of aluminum overload.
Topics: Aluminum; Deferoxamine; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Kidney Failure, Chronic; Renal Dialysis | 1985 |
Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis.
Topics: Aluminum; Anemia; Child; Deferoxamine; Epilepsies, Myoclonic; Humans; Kidney Failure, Chronic; Male; Osteomalacia; Peritoneal Dialysis, Continuous Ambulatory | 1985 |
Clinical features of aluminum-associated bone disease in long-term hemodialysis patients.
Topics: Adult; Aged; Aluminum; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Osteitis Fibrosa Cystica; Radionuclide Imaging; Renal Dialysis; Time Factors | 1986 |
Ultrafiltration studies in vitro of serum aluminum in dialysis patients after deferoxamine chelation therapy.
Topics: Aluminum; Antacids; Blood Proteins; Chromatography, Gel; Deferoxamine; Humans; Infusions, Parenteral; Protein Binding; Renal Dialysis; Spectrophotometry, Atomic; Ultrafiltration | 1985 |
Elevated bone aluminum content in dialysis patients without osteomalacia.
Topics: Adult; Aluminum; Biopsy; Bone and Bones; Deferoxamine; Glomerulonephritis; Histocytochemistry; Humans; Hyperparathyroidism; Ilium; Kidney Failure, Chronic; Male; Middle Aged; Osteitis Fibrosa Cystica; Osteomalacia; Parathyroid Hormone; Renal Dialysis; Vitamin D | 1985 |
Desferrioxamine induced aluminium removal in haemodialysis.
Topics: Aluminum; Deferoxamine; Humans; Renal Dialysis | 1985 |
The desferrioxamine test predicts bone aluminium burden induced by A1(OH)3 in uraemic patients but not mild histological osteomalacia.
Topics: Aged; Aluminum; Aluminum Hydroxide; Bone and Bones; Deferoxamine; Female; Humans; Male; Middle Aged; Osteomalacia; Uremia | 1985 |
Desferrioxamine treatment for aluminium and iron overload in uraemic patients by haemodialysis or haemofiltration.
Topics: Adult; Aluminum; Blood; Deferoxamine; Female; Humans; Iron; Male; Middle Aged; Renal Dialysis; Ultrafiltration; Uremia | 1985 |
Incorporation of aluminium and effect of removal in experimental osteomalacia and fibro-osteoclasia.
Topics: Aluminum; Animals; Bone Resorption; Deferoxamine; Osteomalacia; Rats | 1985 |
The bone scan in patients with aluminium-associated bone disease.
Topics: Aluminum; Deferoxamine; Humans; Hyperparathyroidism, Secondary; Osteomalacia; Radionuclide Imaging; Renal Dialysis | 1985 |
Concomitant removal of aluminium and iron by haemodialysis and haemofiltration after desferrioxamine intravenous infusion.
Topics: Adult; Aluminum; Blood; Deferoxamine; Female; Humans; Iron; Male; Middle Aged; Renal Dialysis; Ultrafiltration | 1985 |
Determination of desferoxamine and a major metabolite by high-performance liquid chromatography. Application to the treatment of aluminium-related disorders.
Topics: Aluminum; Alzheimer Disease; Chelating Agents; Chromatography, High Pressure Liquid; Deferoxamine; Female; Humans; Kinetics; Middle Aged; Spectrophotometry, Ultraviolet | 1985 |
Predictive value of desferrioxamine infusion test for bone aluminium deposits in hemodialyzed patients.
Topics: Adult; Aged; Aluminum; Biopsy, Needle; Bone and Bones; Deferoxamine; Female; Ferritins; Humans; Male; Middle Aged; Renal Dialysis | 1985 |
[Successful treatment of progressive dialysis encephalopathy. Case report].
Topics: Aluminum; Deferoxamine; Dementia; Electroencephalography; Evoked Potentials; Female; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 1985 |
Thrombocytopenia associated with intravenous desferrioxamine.
Topics: Aluminum; Deferoxamine; Humans; Hypotension; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Osteomalacia; Platelet Count; Renal Dialysis; Thrombocytopenia | 1985 |
Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
Topics: Adult; Aluminum; Biopsy; Bone and Bones; Deferoxamine; Dementia; Humans; Hyperparathyroidism, Secondary; Ilium; Middle Aged; Osteomalacia; Parathyroid Hormone; Prospective Studies; Renal Dialysis | 1985 |
Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
Topics: Adult; Aluminum; Anemia, Hemolytic; Blood Transfusion; Deferoxamine; Female; Hematocrit; Humans; Male; Middle Aged; Osteomalacia; Prospective Studies; Renal Dialysis | 1985 |
Kinetics of aluminium removal by desferrioxamine VIA hemodialysis in a case with aluminium bone disease.
Topics: Adult; Aluminum; Bone Diseases; Deferoxamine; Humans; Male; Renal Dialysis | 1985 |
Successful removal of aluminium from patient with dialysis encephalopathy.
Topics: Adult; Aluminum; Brain; Brain Diseases; Deferoxamine; Hemodialysis, Home; Humans; Male | 1980 |
Removal of aluminium from patients with dialysis encephalopathy.
Topics: Adult; Aged; Aluminum; Blood; Brain Diseases; Deferoxamine; Humans; Renal Dialysis; Ultrafiltration | 1980 |
Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.
Topics: Aluminum; Brain Diseases; Deferoxamine; Humans; Male; Renal Dialysis; Water Supply | 1981 |
Treatment of early stages of dialysis encephalopathy by aluminium depletion.
Topics: Aluminum; Apraxias; Brain Diseases; Deferoxamine; Dysarthria; Humans; Male; Renal Dialysis | 1981 |
Treatment of dialysis osteomalacia with desferrioxamine.
Topics: Adult; Alkaline Phosphatase; Aluminum; Bone and Bones; Calcium; Deferoxamine; Electron Probe Microanalysis; Humans; Kidney Failure, Chronic; Male; Osteomalacia; Renal Dialysis; Spectrophotometry, Atomic | 1982 |
Low aluminium water, desferrioxamine, and dialysis encephalopathy.
Topics: Aluminum; Brain Diseases; Deferoxamine; Humans; Renal Dialysis; Water Supply | 1982 |
Successful treatment of aluminium encephalopathy by intraperitoneal desferrioxamine.
Topics: Aluminum; Brain Diseases; Deferoxamine; Female; Humans; Injections, Intraperitoneal; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory | 1984 |
Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy.
Topics: Aluminum; Bone Development; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Humans; Ilium; Infusions, Parenteral; Parathyroid Hormone; Renal Dialysis; Staining and Labeling | 1984 |
Radiographic manifestations of aluminum-induced bone disease.
Topics: Adult; Aluminum; Antacids; Bone Diseases; Deferoxamine; Diphosphonates; Female; Fractures, Spontaneous; Humans; Technetium; Technetium Tc 99m Medronate; Time Factors | 1984 |
The efficacy of various treatment modalities on aluminium associated bone disease.
Topics: Adult; Alkaline Phosphatase; Aluminum; Bone and Bones; Bone Diseases; Deferoxamine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Renal Dialysis | 1983 |
The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure.
Topics: Adult; Aluminum; Bone and Bones; Child, Preschool; Deferoxamine; Female; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Renal Dialysis | 1984 |
Therapy of aluminum overload (I).
Topics: Adult; Aged; Aluminum; Bone and Bones; Brain Diseases; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Long-Term Care; Male; Metabolic Clearance Rate; Middle Aged; Osteomalacia; Renal Dialysis | 1984 |
Effects of subchronic desferrioxamine infusion on aluminum toxicity in rabbits.
Topics: Aluminum; Animals; Body Weight; Deferoxamine; Drinking; Eating; Injections, Subcutaneous; Male; Organ Size; Rabbits; Tissue Distribution | 1984 |
Reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine.
Topics: Aluminum; Catechol O-Methyltransferase; Deferoxamine; Enzyme Reactivators | 1984 |
Successful treatment of dialysis osteomalacia and dementia, using desferrioxamine infusions and oral 1-alpha hydroxycholecalciferol.
Topics: Aluminum; Biopsy; Bone and Bones; Deferoxamine; Dementia; Female; Glomerulonephritis; Hemodialysis, Home; Humans; Hydroxycholecalciferols; Infusions, Parenteral; Middle Aged; Osteomalacia | 1984 |
The EEG in progressive dialysis encephalopathy. The EEG and clinical indices of PDE in cases treated with desferrioxamine. (Part. II).
Topics: Aluminum; Brain Diseases; Deferoxamine; Electroencephalography; Humans; Middle Aged; Neuropsychological Tests; Phenobarbital; Renal Dialysis | 1984 |
Plasma aluminum and iron kinetics in hemodialyzed patients after i.v. infusion of desferrioxamine.
Topics: Adult; Aluminum; Deferoxamine; Female; Humans; Infusions, Parenteral; Iron; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Renal Dialysis | 1984 |
Desferrioxamine and hemofiltration for aluminum removal in patients on regular dialysis treatment.
Topics: Aluminum; Blood; Deferoxamine; Humans; Infusions, Parenteral; Ultrafiltration | 1983 |
Effect of the chelator desferrioxamine on aluminum elimination in rabbits.
Topics: Aluminum; Animals; Deferoxamine; Male; Rabbits; Time Factors | 1983 |
The effect of low aluminum water and desferrioxamine on the outcome of dialysis encephalopathy.
Topics: Adult; Aged; Aluminum; Bone Diseases; Brain Diseases; Deferoxamine; Dementia; Electroencephalography; Female; Humans; Male; Middle Aged; Osmosis; Renal Dialysis; Water | 1983 |
Aluminum kinetics of the REDY system: a study of the impact of deferoxamine therapy.
Topics: Aged; Aluminum; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Models, Biological; Renal Dialysis | 1983 |
Therapy and monitoring of hypersiderosis in chronic renal insufficiency.
Topics: Aluminum; Anemia, Hypochromic; Blood; Blood Transfusion; Combined Modality Therapy; Deferoxamine; Hemosiderosis; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis; Ultrafiltration | 1984 |
Therapy of aluminium overload (II).
Topics: Aluminum; Brain Diseases; Deferoxamine; Humans; Kidney Failure, Chronic; Osteomalacia; Renal Dialysis | 1984 |
Effect of desferrioxamine on aluminum kinetics during hemodialysis.
Topics: Adolescent; Adult; Aged; Aluminum; Deferoxamine; Female; Humans; Kinetics; Male; Middle Aged; Renal Dialysis; Tissue Distribution | 1984 |
Radioenzymatic assay of catecholamines: reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine.
Topics: Aluminum; Catechol O-Methyltransferase Inhibitors; Catecholamines; Deferoxamine; Humans; Methylation; Phenylethanolamine N-Methyltransferase | 1983 |
Treatment of fracturing renal osteodystrophy by desferrioxamine.
Topics: Adult; Aged; Aluminum; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Humans; Kidney Failure, Chronic; Male; Renal Dialysis | 1983 |
[Tissue overload of aluminum in hemodialysis patients. The desferrioxamine test].
Topics: Aluminum; Deferoxamine; Humans; Renal Dialysis | 1982 |
Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
Topics: Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Kinetics; Renal Dialysis | 1981 |
Quantitative evaluation of Al maltolate-induced neurodegeneration with subsequent Al removal by desferrioxamine treatment.
Topics: Aluminum; Animals; Chelating Agents; Deferoxamine; Male; Nerve Degeneration; Organometallic Compounds; Pyrones; Rabbits | 1995 |
Hyperaluminemia associated with liver transplantation and acute renal failure.
Topics: Acute Kidney Injury; Albumins; Aluminum; Ammonia; Antidotes; Chelating Agents; Coma; Deferoxamine; Dialysis Solutions; Enteral Nutrition; Female; Food Additives; Food, Formulated; Humans; Liver; Liver Transplantation; Middle Aged; Organic Chemicals; Renal Dialysis; Seizures | 1995 |
Aluminum levels and stores in patients with total hip endoprostheses from TiAIV or TiAINb alloys.
Topics: Adult; Aged; Alloys; Aluminum; Biocompatible Materials; Bone and Bones; Deferoxamine; Female; Hip Prosthesis; Humans; Male; Middle Aged; Prognosis; Prosthesis Design; Spectrophotometry, Atomic; Time Factors; Titanium | 1995 |
Sodium fluoride stimulates exocytosis at a late site of calcium interaction in stimulus-secretion coupling: studies with the RINm5F beta cell line.
Topics: Aluminum; Animals; Arachidonic Acid; Calcium; Calcium-Binding Proteins; Cell Line; Colforsin; Cyclic AMP; Deferoxamine; Exocytosis; Extracellular Space; Insulin; Insulin Secretion; Ionomycin; Islets of Langerhans; Kinetics; Melitten; Nitrendipine; Potassium Chloride; Protein Kinase C; Secretory Rate; Sodium Fluoride; Stimulation, Chemical; Sulfonamides; Temperature; Terpenes; Tetradecanoylphorbol Acetate; Thapsigargin; Trifluoperazine | 1995 |
Inotropic changes induced by fluoroaluminates in rabbit left atrial muscles: possible involvement of G proteins.
Topics: Aluminum; Animals; Atrial Function, Left; Cyclic AMP; Deferoxamine; Dose-Response Relationship, Drug; Female; Fluorine; GTP-Binding Proteins; Male; Muscle Contraction; Rabbits | 1995 |
Aluminium overload influences cognitive function in patients on dialysis.
Topics: Adult; Aluminum; Brain Diseases; Chelating Agents; Cognition; Deferoxamine; Female; Humans; Male; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1994 |
Binding of aluminium to plasma proteins: comparative effect of desferrioxamine and deferiprone (L1).
Topics: Aluminum; Blood Proteins; Deferiprone; Deferoxamine; Humans; Iron Chelating Agents; Kinetics; Protein Binding; Pyridones; Reference Values; Spectrophotometry, Atomic; Temperature; Thermodynamics; Time Factors; Ultrafiltration | 1994 |
The absence of extracellular calcium potentiates the killing of cultured hepatocytes by aluminum maltolate.
Topics: Aluminum; Animals; Calcium; Cell Death; Cell Membrane Permeability; Cyclic AMP; Deferoxamine; Dose-Response Relationship, Drug; Liver; Male; Mitochondria; Organometallic Compounds; Oxidative Stress; Protein Kinases; Pyrones; Rats; Rats, Sprague-Dawley; Terpenes; Tetradecanoylphorbol Acetate; Thapsigargin; Thionucleotides; Time Factors | 1995 |
Comparative aluminium mobilizing actions of several chelators in aluminium-loaded uraemic rats.
Topics: Aluminum; Animals; Chelating Agents; Citrates; Citric Acid; Deferiprone; Deferoxamine; Female; Injections, Intraperitoneal; Pyridones; Rats; Rats, Sprague-Dawley; Succinates; Succinic Acid; Tissue Distribution; Uremia | 1994 |
Aluminium-related osteodystrophy and desferrioxamine treatment: role of phosphorus.
Topics: Adolescent; Adult; Alkaline Phosphatase; Aluminum; Bone Remodeling; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Ilium; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1994 |
Aluminum retention by aged rats fed aluminum and treated with desferrioxamine.
Topics: Aging; Aluminum; Analysis of Variance; Animals; Bone Remodeling; Deferoxamine; Hydroxyproline; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1994 |
Urinary and biliary excretion of aluminoxamine and ferrioxamine in dogs with various renal function.
Topics: Aluminum; Animals; Bile; Blood Chemical Analysis; Chelating Agents; Deferoxamine; Dogs; Ferric Compounds; Iron Chelating Agents; Kidney; Male; Organometallic Compounds; Urine | 1994 |
[Verification of desferrioxamine ototoxicity by high-frequency audiometry in patients undergoing dialysis].
Topics: Adult; Aluminum; Audiometry; Bone Diseases; Deferoxamine; Dose-Response Relationship, Drug; Female; Hearing Disorders; Humans; Infant, Newborn; Male; Middle Aged; Renal Dialysis | 1994 |
[Interaction between active metabolites of vitamin D3 and blood aluminum in chronic uremic patients on dialysis].
Topics: Adolescent; Adult; Aged; Aluminum; Aluminum Hydroxide; Calcitriol; Chronic Disease; Deferoxamine; Drug Interactions; Female; Humans; Hyperparathyroidism, Secondary; Intestinal Absorption; Male; Middle Aged; Renal Dialysis; Tissue Distribution; Uremia | 1993 |
Anomalous rise of serum osteocalcin following desferrioxamine treatment in aluminium intoxication.
Topics: Aluminum; Bone Development; Calcification, Physiologic; Chromatography, Gel; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Middle Aged; Osteocalcin; Poisoning | 1993 |
Aggregation of tau protein by aluminum.
Topics: 3T3 Cells; Aluminum; Animals; Cattle; Deferoxamine; Electrophoresis, Polyacrylamide Gel; Humans; Mice; Microscopy, Electron; Neurofilament Proteins; Phosphorylation; Recombinant Proteins; tau Proteins; Transfection | 1993 |
Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.
Topics: Adolescent; Aluminum; Biopsy; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Hospitals; Humans; Iron; Male; Parathyroid Hormone; Renal Dialysis | 1993 |
[Aluminum osteopathy--experience with therapy].
Topics: Aluminum; Bone Diseases, Metabolic; Deferoxamine; Female; Humans; Male; Middle Aged; Poisoning; Renal Dialysis | 1993 |
Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.
Topics: Aluminum; Binding, Competitive; Copper; Deferiprone; Deferoxamine; Iron Chelating Agents; Metals; Pyridones; Spectrophotometry | 1993 |
Detection of aluminium(III) binding to citrate in human blood plasma by proton nuclear magnetic resonance spectroscopy.
Topics: Aluminum; Citrates; Deferoxamine; Humans; Magnetic Resonance Spectroscopy; Plasma; Protons | 1993 |
Milestones in the research and development of desferrioxamine.
Topics: Aluminum; Animals; Deferoxamine; History, 20th Century; Humans; Iron; Renal Dialysis | 1993 |
New insights and strategies in the diagnosis and treatment of aluminium overload in dialysis patients.
Topics: Aluminum; Deferoxamine; Humans; Renal Dialysis | 1993 |
Diagnostic and therapeutic approaches to aluminium overload in dialysed patients--representative study by questionnaire in West German dialysis units in 1989-1990.
Topics: Aluminum; Deferoxamine; Dialysis Solutions; Germany, West; Humans; Renal Dialysis; Surveys and Questionnaires | 1993 |
Hemoptysis and altered sensorium in a hemodialysis patient.
Topics: Aluminum; Aluminum Hydroxide; Brain Diseases; Deferoxamine; Hemoptysis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mucormycosis; Poisoning; Renal Dialysis; Vasculitis | 1993 |
Direct effect of deferoxamine on hemoglobin synthesis in patients on hemodialysis treated with recombinant human erythropoietin.
Topics: Aged; Aluminum; Anemia, Hypochromic; Deferoxamine; Erythropoietin; Ferritins; Hematocrit; Hemoglobins; Humans; Iron; Middle Aged; Recombinant Proteins; Renal Dialysis; Transferrin | 1993 |
Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy.
Topics: Aluminum; Anemia; Deferoxamine; Drug Resistance; Erythropoietin; Humans; Kidney Failure, Chronic; Middle Aged; Recombinant Proteins; Renal Dialysis | 1993 |
[Aluminum accumulation and deferoxamine].
Topics: Aluminum; Deferoxamine; Humans; Middle Aged; Poisoning | 1993 |
Altered calcium homeostasis: a possible mechanisms of aluminium-induced neurotoxicity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aluminum; Animals; Brain; Calcium; Calcium Channels; Calcium-Transporting ATPases; Calmodulin; Cell Membrane; Deferoxamine; Glutathione; Homeostasis; Lipid Peroxidation; Male; Membrane Fluidity; Potassium; Protein Kinase C; Rats; Rats, Wistar; Synaptosomes | 1996 |
Aluminum toxicity following intravesical alum irrigation for hemorrhagic cystitis.
Topics: Adolescent; Alum Compounds; Aluminum; Antidotes; Cystitis; Deferoxamine; Electroencephalography; Female; Hemorrhage; Humans; Nervous System Diseases; Therapeutic Irrigation | 1996 |
Fatal Aeromonas hydrophila bacteremia in a hemodialysis patient treated with deferoxamine.
Topics: Aeromonas hydrophila; Aluminum; Antidotes; Bacteremia; Bone Diseases; Deferoxamine; Fatal Outcome; Female; Gas Gangrene; Gram-Negative Bacterial Infections; Humans; Middle Aged; Muscle, Skeletal; Necrosis; Renal Dialysis; Siderophores | 1996 |
DFO low-dose therapy.
Topics: Aluminum; Bone Diseases; Deferoxamine; Dose-Response Relationship, Drug; Humans | 1996 |
Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients.
Topics: Aluminum; Antidotes; Chelating Agents; Data Interpretation, Statistical; Deferoxamine; Drug Administration Schedule; Ferric Compounds; Hemosiderosis; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1996 |
Influence of iron status in the response to the deferoxamine test.
Topics: Aluminum; Antidotes; Deferoxamine; Humans; Iron; Kidney Failure, Chronic; Retrospective Studies; Transferrin | 1996 |
The 3-hydroxypyridin-4-ones more effectively chelate aluminum in a rabbit model of aluminum intoxication than does desferrioxamine.
Topics: Aluminum; Animals; Bile; Chelating Agents; Deferoxamine; Disease Models, Animal; Male; Pyridones; Rabbits | 1996 |
Influence of hydroxypyridones and desferrioxamine on the mobilization of aluminium from tissues of aluminium-loaded rats.
Topics: Aluminum; Animals; Antidotes; Deferoxamine; Disease Models, Animal; Male; Pyridones; Rats; Rats, Wistar; Tissue Distribution | 1995 |
Aluminium-induced bone disease in uremic rats: effect of deferoxamine.
Topics: Adenylyl Cyclases; Aluminum; Animals; Biomechanical Phenomena; Bone and Bones; Bone Diseases; Bone Remodeling; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Osteomalacia; Parathyroid Hormone; Rats; Rats, Wistar; Siderophores; Type C Phospholipases; Uremia | 1996 |
Effect of aluminum on regional brain antioxidant defense status in Wistar rats.
Topics: Aluminum; Animals; Antioxidants; Brain; Catalase; Cerebral Cortex; Deferoxamine; Glutathione; Glutathione Peroxidase; Hippocampus; Lipid Peroxidation; Male; Neostriatum; Rats; Rats, Wistar; Siderophores; Sulfhydryl Compounds; Superoxide Dismutase | 1996 |
Changes of metal concentrations in blood and peritoneal dialysate during long-term desferrioxamine B therapy.
Topics: Adult; Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Male; Metals; Osteomalacia; Peritoneal Dialysis, Continuous Ambulatory; Trace Elements | 1996 |
Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
Topics: Aluminum; Biocompatible Materials; Deferoxamine; Female; Hemofiltration; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Organometallic Compounds; Polycarboxylate Cement; Polymers; Renal Dialysis; Sulfones | 1997 |
Involvement of altered cytoskeletal protein phosphorylation in aluminum-induced CNS dysfunction.
Topics: Aluminum; Animals; Antidotes; Brain Chemistry; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Central Nervous System Diseases; Cyclic AMP-Dependent Protein Kinases; Cytoskeletal Proteins; Deferoxamine; Drug Combinations; Injections, Intraperitoneal; Male; Phosphorylation; Rats; Rats, Wistar | 1996 |
[Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
Topics: Adult; Aluminum; Deferoxamine; Erythropoiesis; Erythropoietin; Female; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1996 |
Aluminium speciation in cerebrospinal fluid of acutely aluminium-intoxicated dialysis patients before and after desferrioxamine treatment; a step in the understanding of the element's neurotoxicity.
Topics: Adult; Aluminum; Citric Acid; Deferoxamine; Female; Humans; Kidney; Male; Middle Aged; Organometallic Compounds; Reference Values; Renal Dialysis; Transferrin | 1997 |
[The causes, diagnosis and treatment of aluminum toxicity in patients with chronic renal failure undergoing dialysis].
Topics: Aluminum; Bone and Bones; Deferoxamine; Humans; Poisoning; Renal Dialysis; Renal Insufficiency; Siderophores | 1996 |
Relative roles of intestinal absorption and dialysis-fluid-related exposure in the accumulation of aluminium in haemodialysis patients.
Topics: Adult; Aged; Aluminum; Bone and Bones; Bone Diseases; Deferoxamine; Dialysis Solutions; Female; Humans; Intestinal Absorption; Male; Middle Aged; Renal Dialysis; Retrospective Studies | 1997 |
Recombinant human erythropoietin resistance in iron-replete hemodialysis patients: role of aluminum toxicity.
Topics: Aluminum; Deferoxamine; Drug Resistance; Erythropoietin; Female; Ferritins; Hematocrit; Humans; Iron; Male; Middle Aged; Recombinant Proteins; Renal Dialysis | 1998 |
Inhibition of the hepatitis C virus helicase-associated ATPase activity by the combination of ADP, NaF, MgCl2, and poly(rU). Two ADP binding sites on the enzyme-nucleic acid complex.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Aluminum; Animals; Beryllium; Binding Sites; Binding, Competitive; Deferoxamine; Hepacivirus; Kinetics; Macromolecular Substances; Magnesium Chloride; Poly U; Pyruvate Kinase; Rabbits; Sodium Fluoride; Viral Nonstructural Proteins | 1998 |
Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Topics: Aluminum; Alzheimer Disease; Animals; Brain; Deferoxamine; Male; Neurofibrillary Tangles; Organometallic Compounds; Pyrones; Rabbits; Spinal Cord; tau Proteins | 1998 |
Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration.
Topics: Aluminum; Chelating Agents; Chromatography, High Pressure Liquid; Deferoxamine; Ferric Compounds; Humans; Organometallic Compounds; Renal Dialysis; Spectrophotometry, Atomic; Time Factors; Uremia | 1998 |
Effects of aluminum ions on K(+)-induced contraction in ileal longitudinal smooth muscle.
Topics: Aluminum; Animals; Calcium; Cations; Chelating Agents; Colon; Deferoxamine; Drug Interactions; Guinea Pigs; Ileum; In Vitro Techniques; Kinetics; Male; Muscle Contraction; Muscle, Smooth; Potassium | 1998 |
Comparative aluminum mobilizing actions of deferoxamine and four 3-hydroxypyrid-4-ones in aluminum-loaded rats.
Topics: Aluminum; Aluminum Compounds; Animals; Chelating Agents; Deferoxamine; Male; Nitrates; Pyridones; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1998 |
Aluminum speciation studies in biological fluids. Part 5. A quantitative investigation of A1(III) complex equilibria with desferrioxamine, 2,3-dihydroxybenzoic acid, Tiron, CP20 (L1), and CP94 under physiological conditions, and computer-aided assessment
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Aluminum; Animals; Body Fluids; Chelating Agents; Computer Simulation; Deferiprone; Deferoxamine; Humans; Hydroxybenzoates; Indicators and Reagents; Inflammation; Iron Chelating Agents; Ligands; Pyridones; Rabbits; Rats; Reproducibility of Results | 1999 |
Interaction of aluminum with PHFtau in Alzheimer's disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method.
Topics: Aluminum; Alzheimer Disease; Antibodies, Monoclonal; Chelating Agents; Deferoxamine; Epitopes; Flavonoids; Histocytochemistry; Humans; Immunoblotting; Neurofibrillary Tangles; Phosphorylation; tau Proteins | 1999 |
Chelation therapy in aluminum-loaded rats: influence of age.
Topics: Aging; Aluminum; Animals; Antidotes; Chelating Agents; Chelation Therapy; Deferiprone; Deferoxamine; Male; Pyridines; Pyridones; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1999 |
Use of a desferrioxamine "microdose" to chelate aluminum in hemodialysis patients.
Topics: Aluminum; Chelating Agents; Deferoxamine; Female; Humans; Male; Middle Aged; Prospective Studies; Renal Dialysis | 1999 |
Aluminium chelation in chronic haemodialysis and aluminium adjuvanted vaccines.
Topics: Adjuvants, Immunologic; Aluminum; Chelating Agents; Deferoxamine; Diphtheria Toxoid; Humans; Renal Dialysis; Tetanus Toxoid | 1999 |
Chelation of aluminium by combining DFO and L1 in rats.
Topics: Aluminum; Animals; Chelating Agents; Deferiprone; Deferoxamine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Iron; Iron Chelating Agents; Pyridones; Rats; Rats, Wistar | 2000 |
Age-Related differences on aluminium mobilization by chelating agents in aluminium-loaded uraemic rats.
Topics: Administration, Oral; Aging; Aluminum; Aluminum Compounds; Animals; Anthelmintics; Chelating Agents; Deferiprone; Deferoxamine; Drug Therapy, Combination; Injections, Subcutaneous; Male; Nitrates; Pyridones; Rats; Rats, Sprague-Dawley; Uremia | 2000 |
Use of ultrafiltration and chromatography to assess aluminum speciation in serum after deferoxamine administration.
Topics: Aluminum; Chelating Agents; Chelation Therapy; Chromatography, High Pressure Liquid; Deferoxamine; Ferric Compounds; Humans; Organometallic Compounds; Ultrafiltration | 2000 |
Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)Al exposure.
Topics: Aluminum; Animals; Brain; Chelating Agents; Deferoxamine; Half-Life; Humans; Male; Mass Spectrometry; Radioisotopes; Rats; Transferrin | 2001 |
The effect of an iron supplement on serum aluminum level and desferrioxamine mobilization test in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Aluminum; Anemia, Iron-Deficiency; Deferoxamine; Female; Ferritins; Humans; Iron; Male; Middle Aged; Renal Dialysis; Uremia | 2001 |
Bone aluminum uptake in uremic rats receiving intraperitoneal iron.
Topics: Aluminum; Animals; Bone and Bones; Deferoxamine; Erythropoietin; Iron; Male; Rats; Rats, Wistar; Renal Insufficiency; Uremia | 2001 |
Steady-state dissolution kinetics of aluminum-goethite in the presence of desferrioxamine-B and oxalate ligands.
Topics: Aluminum; Deferoxamine; Hydrogen-Ion Concentration; Iron Chelating Agents; Iron Compounds; Kinetics; Ligands; Minerals; Oxalates; Solubility | 2002 |
A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease.
Topics: Aluminum; Alzheimer Disease; Brain; Chelating Agents; Deferoxamine; Humans; Immunoblotting; Iron; Monosaccharides; Phosphorylation; Pyridones; tau Proteins | 2003 |
[Effect of desferrioxamine and deferiprone on osteocalcin secretion in osteoblast-type cells].
Topics: Aluminum; Animals; Bone Neoplasms; Calcitriol; Cattle; Chelating Agents; Culture Media; Deferiprone; Deferoxamine; Dose-Response Relationship, Drug; Humans; Osteoblasts; Osteocalcin; Osteosarcoma; Pyridones; Secretory Rate; Serum Albumin, Bovine; Tumor Cells, Cultured | 2003 |
Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum.
Topics: Aged; Aluminum; Ascorbic Acid; Binding Sites; Brain Chemistry; Cell Nucleus; Chelating Agents; Chelation Therapy; Deferoxamine; Diffusion; Drug Synergism; Humans; Molecular Structure; Monosaccharides; Neurodegenerative Diseases; Neuroglia; Neurons; Pyridones; Subcellular Fractions; Terminology as Topic | 2004 |
Arterial calcifications and bone histomorphometry in end-stage renal disease.
Topics: Aluminum; Bicarbonates; Bone and Bones; Bone Density; Calcium; Calcium Phosphates; Chronic Kidney Disease-Mineral and Bone Disorder; Deferoxamine; Female; Humans; Kidney Failure, Chronic; Lipid Metabolism; Male; Osteoblasts; Osteoclasts; Parathyroid Hormone; Renal Dialysis | 2004 |
Aluminum-triggered structural modifications and aggregation of beta-amyloids.
Topics: Aluminum; Amyloid beta-Peptides; Benzothiazoles; Chelating Agents; Circular Dichroism; Deferoxamine; Fluorescent Dyes; Hydrophobic and Hydrophilic Interactions; Liposomes; Peptide Fragments; Protein Conformation; Spectrometry, Fluorescence; Thiazoles | 2005 |
Aluminum toxicity due to intravenous injection of boiled methadone.
Topics: Adult; Aluminum; Ataxia; Chelation Therapy; Deferoxamine; Dysarthria; Humans; Male; Methadone; Poisoning; Seizures; Substance Abuse, Intravenous | 2006 |
Aluminum toxicity following IV use of oral methadone solution.
Topics: Adult; Aluminum; Chelating Agents; Deferoxamine; Humans; Injections, Intravenous; Male; Methadone; Neurotoxicity Syndromes; Treatment Outcome | 2006 |
Is it time to reexamine KDOQI aluminum guidelines?
Topics: Aluminum; Deferoxamine; Humans; Kidney Diseases; Practice Guidelines as Topic; Renal Dialysis; Siderophores | 2006 |
Aluminum inhibits proteolytic degradation of amyloid beta peptide by cathepsin D: a potential link between aluminum accumulation and neuritic plaque deposition.
Topics: Aluminum; Amyloid beta-Peptides; Cathepsin D; Chromatography, High Pressure Liquid; Circular Dichroism; Deferoxamine; Hemoglobins; Humans; Iron; Plaque, Amyloid; Protein Denaturation; Protein Processing, Post-Translational; Protein Structure, Secondary; Zinc | 2006 |
Role of deferoxamine on enzymatic stress markers in an animal model of Alzheimer's disease after chronic aluminum exposure.
Topics: Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Animals; Biomarkers; Brain; Brain Chemistry; Chelating Agents; Deferoxamine; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Transgenic; Stress, Physiological | 2011 |
Metal ion-mobilizing additives for comprehensive detection of femtomole amounts of phosphopeptides by reversed phase LC-MS.
Topics: Adsorption; Aluminum; Amino Acid Sequence; Ascorbic Acid; Chromatography, Reverse-Phase; Coordination Complexes; Deferoxamine; Imidazoles; Iron; Molecular Sequence Data; Nanotechnology; Peptide Fragments; Phosphoproteins; Phosphorus; Reference Standards; Titanium | 2011 |
Aluminum does not enhance beta-amyloid toxicity in rat hippocampal cultures.
Topics: Aluminum; Amyloid beta-Peptides; Animals; Cell Death; Cell Survival; Chelating Agents; Clioquinol; Deferoxamine; Drug Synergism; Hippocampus; Neuroglia; Neurons; Quinic Acid; Rats | 2010 |
Aluminium induced structural, metabolic alterations and protective effects of desferrioxamine in the brain tissue of mice: an FTIR study.
Topics: Aluminum; Animals; Brain; Chelating Agents; Deferoxamine; Lipid Peroxidation; Male; Mice; Spectroscopy, Fourier Transform Infrared | 2012 |
Determination of aluminium induced metabolic changes in mice liver: a Fourier transform infrared spectroscopy study.
Topics: Aluminum; Animals; Chelating Agents; Deferoxamine; Lipid Peroxidation; Liver; Male; Mice; Proteins; Spectroscopy, Fourier Transform Infrared | 2013 |
FT-Raman study of deferoxamine and deferiprone exhibits potent amelioration of structural changes in the liver tissues of mice due to aluminum exposure.
Topics: Aluminum; Animals; Chelating Agents; Deferiprone; Deferoxamine; Liver; Male; Mice; Pyridones; Spectroscopy, Fourier Transform Infrared | 2014 |
FTIR study of protective action of deferoxamine and deferiprone on the kidney tissues of aluminum loaded mice.
Topics: Aluminum; Animals; Chelating Agents; Deferiprone; Deferoxamine; Kidney; Male; Mice; Protective Agents; Pyridones; Spectroscopy, Fourier Transform Infrared | 2014 |
Iron and aluminum in Alzheimer's disease.
Topics: Aged; Aluminum; Alzheimer Disease; Antioxidants; Ascorbic Acid; Chelation Therapy; Deferoxamine; Epilepsy; Fatal Outcome; Female; Humans; Iron; Siderophores | 2013 |
Studies the alterations of biochemical and mineral contents in bone tissue of mus musculus due to aluminum toxicity and the protective action of desferrioxamine and deferiprone by FTIR, ICP-OES, SEM and XRD techniques.
Topics: Aluminum; Animals; Bone and Bones; Deferiprone; Deferoxamine; Iron Chelating Agents; Male; Mice; Microscopy, Electron, Scanning; Minerals; Protective Agents; Pyridones; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2014 |
Protective effects of desferrioxamine and deferiprone on the spleen tissue of aluminum intoxicated mice: A Fourier transform infrared spectroscopy study.
Topics: Aluminum; Animals; Deferiprone; Deferoxamine; Male; Mice; Protective Agents; Pyridones; Spectroscopy, Fourier Transform Infrared; Spleen | 2014 |
Desferrioxamine and desferrioxamine-caffeine as carriers of aluminum and gallium to microbes via the Trojan Horse Effect.
Topics: Aluminum; Anti-Bacterial Agents; Antioxidants; Caffeine; Candida albicans; Deferoxamine; Dose-Response Relationship, Drug; Drug Carriers; Escherichia coli; Gallium; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 2017 |
Isolation and characterization of iron chelators from turmeric (Curcuma longa): selective metal binding by curcuminoids.
Topics: Aluminum; Animals; Binding, Competitive; Calcium; Cell Line; Chromatography, Affinity; Copper; Curcuma; Curcumin; Deferoxamine; Diarylheptanoids; Edetic Acid; Epithelial Cells; Ferric Compounds; Iron; Iron Chelating Agents; Kinetics; Liver; Magnesium; Manganese; Nitrilotriacetic Acid; Plant Extracts; Rats; Zinc | 2017 |
Interference-Enhanced Raman Spectroscopy as a Promising Tool for the Detection of Biomolecules on Raman-Compatible Surfaces.
Topics: Aluminum; Aluminum Oxide; Deferoxamine; Equipment Design; Ferric Compounds; Polymethyl Methacrylate; Spectrum Analysis, Raman; Surface Properties | 2018 |
Aluminum overload in the reverse osmosis dialysis era: does it exist?
Topics: Alkaline Phosphatase; Aluminum; Aluminum Compounds; Anemia; Calcium; Deferoxamine; Erythropoietin; Humans; Osmosis; Phosphates; Renal Dialysis | 2022 |